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Abstract 
 The synthesis of carbon-nitrogen (C-N) bonds is an area of research that has 
garnered significant interest due to the ubiquity of C-N bonds in pharmaceuticals and 
natural products. Various methods exist for forming C-N bonds, most recognizably 
Buchwald-Hartwig amination, but these reactions typically require functionalization of 
either the C-H or N-H bond resulting in the formation of harmful byproducts. As a 
result, the need to explore alternative means for synthesizing C-N bonds merits 
consideration. An alternative means for achieving C-N bond formation lies in the 
oxidative cross coupling of carbon-hydrogen (C-H) and nitrogen-hydrogen (N-H) 
bonds. While this approach eliminates the necessity for the prefunctionalization of C-
H and N-H bonds, reactions employing oxidative cross coupling can be plagued with 
poor regioselectivity. As a result, the use of directing groups and transition metal 
catalysis is typically employed to circumvent this issue.  
 The primary focus of this dissertation is the discussion of newly developed 
methodologies that enhance the regioselective control of oxidative C-N bond 
formation. Chapters one and two detail the use of hypervalent iodine in conjunction 
with a transition metal catalyst to help govern the site of amination on various 
electron-rich, and moderately deactivated, arene systems. Chapters three and four will 
deviate from C—N bond forming methodologies and instead discuss synthetic routes 
for the construction of a molecular probe targeting the D2 receptor and the 
development of an amino acid coupling protocol to be utilized in the organic teaching 
laboratory. 
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Preface 
This dissertation is presented in manuscript format. The first manuscript 
entitled “Regioselective Gold Catalyzed Oxidative C-N Bond Formation” discusses 
the effects of a gold (I) catalyst when oxidatively coupling phthalimide to simple 
arenes in the presence of hypervalent iodine. Mechanistic insight suggests a pathway 
consistent with that of electrophilic aromatic substitutionwith a preference to impart 
para selectivity. This manuscript has been published as a communication in Organic 
Letters. 
 The second manuscript entitled “Regioselective C—N Bond Formation by 
Aminoiodanes” employs a copper (II) reagent for an economical means of aminating 
various 2-phenylpyridine derivatives. The manuscript detailing this work has been 
published in Chemical Communications. 
 The third manuscript entitled “Efforts Towards the Synthesis of a Molecular 
Probe targeting the D2 Receptor” deviates from C-N bond formation and focuses on 
the synthetic methodology employed for the probe’s construction. Upon the 
completion of the synthesis this work will be submitted for publication to the Journal 
of Organic and Biomolecular Chemistry. 
 The final manuscript entitled “Solution-Phase Synthesis of Dipeptides: A 
Capstone Project that Employs Key Techniques in an Organic Laboratory Course” is 
an original laboratory experiment designed to serve as a final assessment of the skills 
acquired throughout the sophomore level organic chemistry laboratory course. This 
work has been accepted in the Journal of Chemical Education. 
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 1 
Introduction 
 The field of carbon–nitrogen (C–N) bond formation has generated significant 
attention due to the ubiquity of C–N bonds in a verity of biologically active 
compounds. Reactions seeking to achieve C–N bond formation can be done in one of 
two ways: either intramolecularly, resulting in the formation of a heterocyclic 
compound; or intermolecularly, wherein a nitrogen-containing compound is 
independently coupled to some carbon species.1 C–N bond formation can be achieved 
in a myriad of ways. However, from an environmental perspective, the best way to 
achieve C–N bond formation is through the oxidative cross coupling of carbon–
hydrogen (C–H) and nitrogen–hydrogen (N–H) bonds, as this would eliminate the 
need for prefunctionalization of the C–H bond and would, in principle, increase the 
atom economy of the overall synthesis. While the use of transition metal catalysts are 
not always necessary, regioselectivity often becomes an issue when attempting to 
perform a reaction intermolecularly using oxidative conditions.2-4 As a result, 
contemporary methods employed for the oxidative construction of C–N bonds often 
utilize directing groups or late transition metals in order to garner control over the site 
of amination.  Herein, a discussion highlighting contemporary methods for the 
construction of C–N bonds utilizing different transition metal catalysts will be 
presented with an emphasis on C–H prefunctionalization alternatives when applicable.  
Palladium Catalysis 
 Perhaps the most recognized amination protocol is the one that is now taught to 
students in sophomore organic chemistry, the Buchwald-Hartwig reaction. In 1995 
 2 
Steven Buchwald reported that the C–N bond of an N-arylamine could be formed by 
reacting aryl bromides with secondary amines in the presence of a base and catalytic 
amounts of palladium (Scheme 1).5 While examples of C–N bond formation certainly 
exist before 1995, the preceding example remains one of the most widely utilized 
procedures today.   
 
Scheme 1. Buchwald amination reaction5 
The field of oxidative C–H amination employing a palladium catalyst is 
markedly less developed when compared to reactions yielding carbon-carbon (C–C) 
bonds.1 Moreover, the intramolecular reaction has been more studied in comparison to 
its intermolecular counterpart. The syntheses of carbazoles and indoles have been 
extensively studied and, in the case of carbazole synthesis, demonstrated good 
functional group tolerance.1 By taking advantage of the thermodynamically favored 5-
membered palladacycle intermediate, the need for C–H bond functionalization is 
circumvented in both instances through the additional use of stoichiometric amounts 
of copper6,7 or hypervalent iodine8 (Scheme 2).  
In addition to carbazoles and indoles, the synthesis of indolines and lactams 
have also shown to be quite amenable to palladium catalyzed reactions.7,9  Much like 
the synthesis of carbazoles, reactions producing indoline derivatives also exhibited 
excellent functional group tolerance with considerable success being achieved across a 
R
Br HNR1R2
cat. Pd. tBuNa
65o C or 100o C
Toluene
R
N
R2
R1
+
 3 
modest array of phenethyltriflamides.1 Lactam synthesis also proved to be fairly 
fruitful as high yields were achieved in reactions producing β-, γ- , and δ-derivatives; 
however, the major drawback to this work was the necessity for a high degree of 
substitution α to the carbonyl of the amide functional group.1,7 
 
Scheme 2. Intramolecular synthesis of carbazoles and indazoles1,7-8 
 Few examples of intermolecular palladium catalyzed amination reactions exist 
via C–H activation. In 2006 Che and associates reported the successful amination of 
pyridine and oxime ether derivatives.10 Che demonstrated that catalytic amounts of 
palladium in the presence of excess K2S2O8 were effective in transferring an amide 
moiety.1 The electronics of the amide derivative proved to be inconsequential as 
electron deficient systems were demonstrated to be amenable to Che’s protocol 
(Scheme 3).   
 
I
10 mol % [Pd]
1.2 equiv. PIDA
Toluene, rt, 12 h
N iPr
N
H
iPr
71%
10 mol % [Pd]
1 equiv Cu(OAc)2
DMSO
80o C, 24 hNHTs
N
Ts
84%
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Scheme 3. Amination of oxime ethers10 
Most recently, Hartwig and coworkers developed a method for regioselectively 
coupling phthalimide to sterically encumbered arenes using catalytic amounts of 
palladium and hypervalent iodine.11 While Hartwig’s findings provided high yielding 
substrates, his methodology was limited in that regioselectivity was governed by 
sterics, and owing to the fact that the proposed mechanism proceeded through 
concerted metalation-deprotonation (CMD), little selectivity between para and meta 
substituted isomers were observed. 
Copper Catalysis 
 C–N bond formation is substantially more developed with regards to copper 
catalysis, and an excellent review exists highlighting major accomplishments in the 
field.12 For example, one of the better-known copper catalyzed amination reactions 
involves the arylation of arylamines, the Ullmann coupling reaction. In this reaction, 
aryl-halides may be coupled to aniline derivatives, or N-containing heterocycles, in the 
presence of a copper catalyst to yield the corresponding aryl/diarylamines (Figure 1).12 
N O
5 mol % [Pd]
1.2 equiv H2NCO2CH3
5 equiv K2S2O8
DCE, 80o C, 16 h
N O
NHCO2CH3
 5 
 
Figure 1. Arylation of N-heterocycles12 
 Ullmann coupling is typically not amenable to aliphatic systems, i.e. 
alkylamines, with the exception of chelating amines such as amino acids.12 It was not 
until 2003, when Fukuyama published a communication detailing the arylation of 
primary amines, that copper catalyzed C–N bond formation was extended to aliphatic 
systems.13  
 Perhaps as equally robust as the Ullmann reaction, though admittedly less 
advantageous, is the Goldberg condensation of primary amides. Shortly after the 
development of the Ullmann reaction Irma Goldberg developed a method for arylating 
amide and aniline substrates.12 In this derivation of the Ullmann reaction, a primary 
amide and aryl halide undergo a cross coupling reaction in the presence of copper and 
potassium carbonate to afford the desired arylamide (Scheme 4). While the utility of 
HN
H
N
N
HN NHN
HN
N
N
N
N
N
HN
HN HN
N
HN
N
HN
NN
HN
N
R
R
HN HN
N
N
HN
N
O OOH
Ar NHetH NHetAr X
Copper Cat.
+
H NHet =
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both this reaction and Ullmann coupling is extensive, attention should be diverted to 
the development of oxidative processes that circumvent the use of aryl halides. 
 
Scheme 4. Representative Goldberg Condensation Reaction 
 Oxidative C–N bond formation via C–H activation is underdeveloped in the 
sphere of copper catalysis. However, over the last decade advances have been made to 
develop intermolecular pathways for direct C–H amination. In 2006 Yu and associates 
published their findings that 2-phenylpyridine derivatives, in the presence of catalytic 
Cu under an O2 atmosphere, had the ability to couple nucleophilic species α to the 
pyridine directing group.14 This reaction appears to be facilitated by the formation of a 
5-membered ring intermediate (Scheme 5).  
 
Scheme 5. Amidation of 2-phenylpyridine 
N
H
O
NH2
O
Br+
Cat. Cu
K2CO3
NO2Ph, reflux
N 20 mol % CuOAc
tol/o-dichlorobenzene (1:1)
O2, 150o C
N
NPhth
NH
O
O
Cu
N
NPhth
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Recently, Shen and associates expanded upon Yu’s work and detailed the 
direct amination of various N-heteroarylindoles and 2-arylpyridine substrates. While 
the reaction is robust in most instances, with yields ranging from 20-97%, the 
oxidative coupling of amine/amide moieties into aromatic systems appears to be 
limited to substrates containing a chelating directing group.15  
Gold Catalysis 
 Over the course of the last two decades reactions employing a gold catalyst 
have been on the rise despite the long held assumption that gold was an unreactive 
noble metal.16 Unlike the previously mentioned examples, most of the reactions 
utilizing a gold catalyst occur through a hydroamination process, i.e. the formal 
addition of a N–H bond across an unsaturated C–C bond.16 Gold catalysis is 
particularly useful in the formation of allylic amines which can serve as valuable 
synthetic precursors (Scheme 6).  
 
 
Scheme 6. Gold catalyzed allylic amine synthesis17 
Similarly, gold can be a useful tool in the synthesis of propargyl amines. 
Conventional routes for synthesizing propargyl amines can become overly 
complicated, as procedures will typically call for the reaction of imine derivatives with 
water-sensitive reagents such as lithium acetylides or Grignard reagents.16 
Et
NH
Et
C
R2
R1 5 mol % [Au]
5 mol % KB(C6F5)4 R2
R1
N
Et
Et+
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Alternatively, propargyl amines may be synthesized from gold salts, such as AuBr3 
and AuCl, by coupling an alkyne, aldehyde, and amine by C–H activation (Scheme 7). 
This method does however possess minor drawbacks, as gold salts have a tendency to 
rapidly reduce into an inert metal species upon olefin activation.16 Despite this 
inevitability, considerable progress has been made towards the synthesis of propargyl 
amines using this reaction.18-21  
 
Scheme 7. Gold mediated propargyl amine synthesis  
Recently, the use of gold catalysis has demonstrated effectiveness to aminate 
unsaturated C–C bonds intramolecularly. In 2009 Chen et al. reported a gold catalyzed 
reaction of various 2-tosylaminophenylprop-1-en-3-ol derivatives, leading to the 
construction of 1,2-dihydroquinolines. These reactions were also carried out in the 
presence of AgSbF6 and produced yields ranging from 42-91% (Scheme 8).22 This 
reaction was unique because of it’s high functional group tolerance. The procedure 
was amenable to electron-withdrawing, electron-donating, and sterically encumbered 
substrates.  
 
Scheme 8. Allylic amination of 2-tosylaminophenylprop-1-en-3-ols 
RCHO + R' + R"2NH
cat. [Au]
H2O
NR"2
R'
NHTs
R
R OH
AuCl3
AgSbF6
Toluene, r.t. 1h
N
Ts
R
R
 9 
 Expanding on Chen’s work, Widenhoefer employed a similar protocol for the 
synthesis of pyrrolidine and piperidine derivatives from alkylamine precursors.23 
Widenhoefer’s methodology required increased time and temperature in comparison to 
Chen, but excellent enantioselectivity was observed with ee’s as high as 96% (Scheme 
9).  
 
Scheme 9. Enantioselective piperidine synthesis 
 Few examples of gold catalyzed arene aminations exist in the literature; the 
first was reported by He and coworkers. In 2007 He achieved direct functionalization 
of aromatic C–H bonds and detailed a gold catalyzed nitrene insertion pathway that 
resulted in aryl and benzylic amination.24 More recently, Zhang reported the direct 
amination of arenes using azodicarboxylates. His gold(III) mediated pathway 
represented the first catalytic system for the direct amination of electron-deficient 
arenes with azodicarboxylates. Zhang’s conditions were mild, with temperatures not 
exceeding 60° C, and produced yields as high as 96% (Scheme 10).25 With the 
exception of the previous two examples, and the work detailed herein, the topic of 
intermolecular arene amination is significantly underdeveloped with respect to gold 
catalysis. 
Bn
NH
OH
Bn
N
AuCl
AgSbF6
dioxane, 100o C, 14 h
96% ee
 10 
 
Scheme 10. Direct arene amination25 
 Methods for C–N bond formation will always be an important synthetic tool in 
the construction of various pharmaceuticals and natural products. The necessity to 
develop greener, more atom efficient methods for amination protocols have only just 
started to take hold in the scientific community, as catalytic, oxidative alternatives 
begin to emerge. In order for oxidative C–N bond formation to really take root in 
academic and industrial practices, alternatives to reactions such as Buchwald-Hartwig 
coupling and Ullmann coupling need to be developed without sacrificing yield and 
regioselectivity. While oxidative C–H activation may still be relatively 
underdeveloped with respect to other contemporary amination strategies; in just a 
short time we have seen substantial progression in the field. It can be said with 
confidence that it may only be a matter of time before our contemporary methods are 
viewed as outdated and obsolete as oxidative catalysis begins to take hold. 
 
 
 
 
R' N
N
R
R AuCl3
r.t. - 60o C
+ R
N
R
NH
R
R' = EDG 
   or EWG
R'' = CO2iPr
or CO2CH2CCl3
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Manuscript 1 
Regioselective Gold-Catalyzed Oxidative C—N Bond Formation 
 
Abstract 
 
A novel protocol for the regioselective intermolecular amination of various 
arenes has been developed. By using an I(III) oxidant in the presence of an Au(I) 
catalyst, a direct, and novel route for regioselectively accessing a variety of substituted 
aniline moieties has been achieved with yields as high as 90%. Mechanistic insight 
suggests that regioselectivity can be predicted based on electrophilic aromatic 
metalation patterns. 
Introduction 
The synthesis of carbon–nitrogen (C–N) bonds through the oxidative cross-
coupling of carbon-hydrogen (C–H) and nitrogen–hydrogen (N–H) bonds is an area 
that has generated significant interest due to the ubiquity of C–N bonds in a variety of 
pharmaceuticals and natural products. The utility of late-stage transition metals, more 
specifically Pd, Rh, Ru and Cu, for C–H bond activation has been extensively studied 
and the research field has been reviewed several times.1 Over the course of the last 
two decades, gold-catalyzed reactions have played a significant role in carbon–carbon 
R
cat. Cy3P-Au-Cl
 PhI(OAc)2
+ NH
O
O
R
H
electrophilic mechanism 
imparts para selectivity
N
O
O
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(C–C), carbon-oxygen (C–O) and C–N bond forming methodologies, despite the long-
held assumption that gold was an unreactive noble metal.2  
Recently, the use of gold catalysis has been explored for the purposes of C–H 
activation; however, few precedents exist.3 The majority of the work in gold-catalyzed 
C–N bond formation involves hydroamination processes,4 though one example of 
arene amination via nitrenes has also been reported.3b  Herein, we report a novel gold-
catalyzed reaction that regioselectively synthesizes the C–N bond of phthalimide-
protected aniline moieties by oxidatively cleaving C–H and N–H bonds.  
We, along with Chang and Antonchick, recently reported the metal-free 
synthesis of phthalimide-protected aniline derivatives utilizing phenyliodine(III) 
diacetate (PIDA), phthalimide, and various simple arene substrates.5 While this 
reaction was high yielding, it was plagued with poor regioselectivity.  In a subsequent 
communication, Hartwig disclosed that introducing catalytic amounts of Pd(OAc)2 
into the reaction greatly enhanced the regioselectivity.6 The use of the palladium(II) 
catalyst also resulted in a lowering of the reaction temperature, but it required 
additional equivalents of the oxidant, relative to the metal-free conditions. While 
Hartwig was able to enhance regioselectivity, product formation was almost 
exclusively governed by sterics and, owing to the fact that the palladium-catalyzed 
reaction proceeded via a concerted metalation deprotonation (CMD) pathway, 
regioselectivity between meta and para-substituted regiomers was generally not 
observed (Scheme 1). 
 16 
 
Scheme 1. Regioselectivity of oxidative amination as a function of catalyst 
Results and Discussion 
We hypothesized that transition metal catalysts that do not metallate arenes by 
the CMD mechanism would further enhance the regioselectivity of our original 
findings, and we quickly discovered that heating a solution of 
chloro(triphenylphosphine)gold(I), phthalimide (1), and PIDA in o-xylene resulted in a 
56% conversion of 1 to the desired phthalimide-protected aniline derivatives, 2a and 
2b, in a 7:93 ratio, as determined by gas chromatography. Excited by this new lead, we 
began the optimization process by probing the role of PIDA in the reaction. By 
conducting control reactions and varying the loading of PIDA, several important 
trends were observed (Table 1).  
First, the necessity for hypervalent iodine in the reaction was illustrated when 
PIDA was completely omitted from the reaction (Entry 1). Additionally, we observed a 
steady increase in the conversion of 1 to the desired phthalimide-protected aniline 
derivative (2) until the reaction plateaued at 4 equiv of PIDA (Entries 2-7).  
 
 
Me
catalyst
PhI(OAc)2+
NH
O
O
Me
PhthN
catalyst
none
Pd(OAc)2
Cy3PAuCl
major isomer(s)
o/m/p mixture
m/p mixture
para
ref
5
6
this
work
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entrya PIDA (equiv) [Au] (equiv) % Yield (2a+2b)b 2a:2b
b 
1 0 0.10 2 % 100:0 
2 1 0.10 24% 9:91 
3 2 0.10 56% 7:93 
4 3 0.10 69% 7:93 
5 5 0.10 73% 8:92 
6 4 0.10 77% 7:93 
7c 4 0.10 93% 6:94 
8 4 0 12% 2:1 
a General reaction conditions: 1 (0.10 mmol), PIDA (0-5 equiv), 3.0 mL reagent grade o-xylene (solvent), aluminum well-plate 
heating at 100 °C for 24 hours.  b Yield and product ratio obtained via GC; see Supporting Information for details.  c Assembled 
in a nitrogen-containing glove box, anhydrous o-xylene 
Table 1. Control and Optimization Results 
One key facet of the data that could not be ignored was the ability for the 
amination to proceed in the absence of a gold catalyst, albeit with a low conversion 
(Entry 8). It appears that the radical-mediated pathway reported in our original 
communication could not be completely inhibited. However, the presence of gold 
dramatically impacted regioselectivity (compare entries 7 and 8). As a result, we 
Me
+
Me
NH
O
O
Me
Me NPhth
Me
Me
NPhth
+
Ha
Hb
2a
2b
1solvent
 Ph3P-Au-Cl
X equiv PhI(OAc)2 
100 oC, 24 h
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hypothesized that two competing reaction pathways were taking place in these 
reactions, with metalation of the arene by the gold catalyst being favored over the non-
catalyzed amination that we previously described. Other hypervalent iodine sources 
such as phenyliodine(III) bis(trifluoroacetate) (PIFA), and 2-iodoxybenzoicacid (IBX) 
were not amenable to this amination; nor were other metal-based oxidants, such as 
silver acetate.  
Attempting to further enhance starting material conversion, we sought to 
determine if the reaction was stalling as a result of catalyst decomposition or oxidant 
consumption. A phosphorus NMR of the crude reaction mixture showed that the 
original gold catalyst still remained in solution. Drawing inspiration from Hartwig’s 
Pd-catalyzed amination, we began adding additional equivalents of oxidant throughout 
the course of the reaction.6 It was ultimately determined that by adding an additional 4 
equiv of PIDA to the reaction after 12 hrs, a moderate increase in yield could be 
obtained without impacting regioselectivity.  Both the gold-catalyzed reactions that are 
described herein and the previously described palladium catalyzed and metal-free 
aminations, also form biaryl side products, thus at least partially accounting for the 
need for additional equivalents of the oxidant.  
 Upon the completion of the oxidant screen, we sought to further enhance the 
conversion of starting material and the regioselectivity by probing the effects of 
different phosphine ligands (Table 2). Various gold-phosphine complexes were 
synthesized according to known precedures7 and then subjected to the optimized 
reaction conditions. Bulky biaryl-containing ligands exhibited a drop-off in 
conversion, while trialkylphosphine ligands provided enhanced conversion of the 
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starting material and simultaneously preserved the lead reaction’s regioselectivity. It 
was ultimately decided to continue the investigation with tricyclohexylphosphine due 
to its ease of handling. It is also worth mentioning that decreasing catalyst loading 
severely reduced the reaction rate, while an increase in catalyst loading only modestly 
impacted regioselectivity. 
 
entrya ligand % Yield (2a+2b) b 2a:2b
b 
1 PPh3 93% 6:94 
2 Tetrahydrothiophene 54% 6:94 
3 Triethyl Phosphite 73% 6:94 
4 MePhos 20% 15:85 
5 DavePhos 13% 46:56 
6 TrixiePhos 92% 10:90 
7 Cy3P 98% 6:94 
8 (i-Pr)3P 97% 4:96 
a See Table 1 for reaction conditions.  Reactions assembled in a nitrogen-containing glove box.  b Yield and product ratio 
obtained via GC; see Supporting Information for details. 
Table 2. Phosphine Ligand Synthesis 
Me 10 mol % L-Au-Cl
4 equiv PhI(OAc)2 
100 oC, 24 h
+
Me
NH
O
O
Me
Me NPhth
Me
Me
NPhth
+
Ha
Hb
2a
2b
1solvent
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 Subsequently, a variety of simple arenes with various functionalities were 
subjected to the optimized reaction conditions. These experiments indicated that our 
protocol appeared to be most amenable to electron-rich systems. As a result, our 
substrate scope illustrates the effects of the gold-catalyzed reaction on various 
halogenated arenes and arenes possessing electron-donating groups (EDG) (Table 3). 
The benefit of the gold catalyzed reaction lies in its significantly enhanced 
regioselectivity. While conducting a similar reaction with other transition metals, such 
as palladium, may allow for amination of more electron-deficient systems,6 the gold-
catalyzed reaction provides significantly enhanced regioselectivities favoring para-
substituted isomers.  We hypothesize that this is the result of an alternate mechanism 
that differs from our previously reported metal-free radical initiated pathway, and 
Hartwig’s palladium-catalyzed CMD pathway.5,6 The substitution patterns observed in 
the gold-catalyzed reaction appear to be governed by the same set of constraints 
observed in electrophilic aromatic substitution. Moreover, the predominant para- 
selectivity can be attributed to the large gold atom’s preference to avoid positioning 
itself ortho to substituents. 
 Perhaps the most significant argument that can be made regarding whether or 
not the reaction is more heavily influenced by electronics or sterics is best illustrated 
by 10. In the amination of m-xylene, a clear preference for amination to occur para 
with respect to either of the methyl groups is observed, rather than aminating at the 
less sterically encumbered position. 
Minor meta-substituted products were also observed in reactions producing 4-
8, 10 and 11, all of which are derived from less electron-rich arene substrates. The 
 21 
exception to this rule is the amination of chlorobenzene (6), which surprisingly 
provided exclusive para-amination. We hypothesize that the meta-substituted products 
originate from a competing mechanism, the metal-free, radical-mediated reaction 
pathway. The meta-isomers are more often observed in less electron-rich systems, 
where electrophilic aromatic metalation (EAM) should be much slower. The inverse of 
this phenomenon is also illustrated in the reaction of the more electron-rich anisole 
substrate (3), which exhibits no meta-substitution, presumably because EAM is the 
dominant reaction pathway.  
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a Regioselectivities determined via GC/MS against standards. 
Table 3. Arene Substrate Scope 
 Having successfully established the substrate scope, we sought to further 
elucidate the reaction mechanism. To do this we first probed the kinetic isotope effect 
by performing a competition reaction using an equimolar solution of 
benzene/benzene-d6. A KIE value of 1.04 was obtained, which rules out the possibility 
1) 4 equiv PhI(OAc)2 
    10 mol % Cy3P-Au-Cl
    Arene (solvent), 100 oC, 24 h
2) 4 equiv PhI(OAc)2 after 12 h
NH
O
O
NPhth
1
R
N
O
O
6, 27%
o:m:p = 0:0:1
9, 30%
a:b = 1:4
3, 78%
o:m:p = 1:0:6
8a, 68%
o:m:p = 0:1:2
MeO
10a, 27%
a:b:c = 1:8:1
12, 56%
o:m:p = 2:0:3
N
O
O
13, 75%
N
O
O
2, 90%
a:b = 1:30
Me
Me
a
b
11a, 76%
o:m:p = 1:5:13
5, 25%
o:m:p = 1:2:12
N
O
O
4a, 67%
o:m:p = 1:2:9
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7, 39%
o:m:p = 0:1:4
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O
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O
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O
N
O
O
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O
I
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b
N
O
O
a
b
c
N
O
N
O
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EtO
O O
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of a gold-mediated C-H activation contributing to the rate-determining step, and 
demonstrates that a CMD pathway is unlikely. In order to substantiate our claim that 
this reaction proceeds via EAM, additional internal competition reactions were 
performed (Table 4). By carrying out the amination procedure in an equimolar mixture 
of an electron-rich arene with a comparatively electron-deficient arene we observed 
that amination of the more electron-rich system was dramatically favored in both 
instances. These findings support the hypothesis that the observed regioselectivity 
patterns were likely the result of EAM and lead to the proposed mechanism detailed in 
Scheme 2. 
 
 
 
Ar1-H Ar2-H 
χa 
PhthN-Ar1 
χa 
PhthN-Ar2 
Anisole Benzene 87 13 
Fluorobenzene Benzene 20 80 
a Mole fractions determined by GC/MS 
Table 4. Competition Reactions 
The proposed Au(I)/Au(III) pathway is initiated by the oxidation of the Au(I) 
species to form Au(III) as the active catalyst.  The para selectivity of this process is 
4 equiv PhI(OAc)2 
10 mol % Cy3P-Au-Cl
100 oC, 24 h
NH
O
O
NPhth
+
R1
R2
R2
NPhth
R1
equimolar mixture
Ar1–H
Ar2–H
+
+
1
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consistent with other Au-catalyzed halogenation, oxygenation and arylation reactions 
that have been previously reported.3c-e The Au(III) catalyst could then metalate either 
the ortho- or para-positions, with the para-position being presumably more favored. 
The metallated arene then proceeds to interact with an in situ-generated iodane species 
(14) via transmetalation. Once the imide reagent has been incorporated onto the gold 
species, the complex undergoes reductive elimination to afford the desired N-coupled 
product while regenerating the gold (I) catalyst.  
 
 
 
 
 
 
(a) Oxidation, (b) EAM, (c) Transmetalation, (d) Reductive elimination.  EDG = electron donating 
group, X = OAc or Cl, L = Cy3P 
 
Scheme 2. Proposed Reaction Mechanism 
 In order to determine if 14 was a plausible intermediate for this reaction, we 
synthesized the N,N-diphthalimidoiodane, 15.8 When this iodane was subjected to the 
reaction (instead of phthalimide), an isolated yield of 38% was observed with a 
regioselectivity comparable to the parent reaction (Scheme 3). 
L-Au-X
L-Au
OAc
EDG
Au
X
L
I
Ph
PhthN OAc
I
X
EDG
Au
X
L
+
PIDA + H-NPhth
EDG
PhthN
bc
d
14
EDG
PIDA
a
OAc
X
HX
PhthN
X
I
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Scheme 3. Iodane-Mediated Amination 
 The success of this reaction indicates that transmetalation from a phthalimide-
containing iodane intermediate is a viable reaction pathway. Our hypothesis for the 
formation of 14 is also supported by our observation of a moderate amount of the 
acetoxylated arene as a minor reaction product. We hypothesize that 15 allows for 
transfer of either the N- or O-ligand via transmetalation. Alternatively, a nucleophilic 
Au–arene species could directly attack the electrophilic nitrogen in 14 (not shown). 
Future studies will be directed towards isolating N,O-iodanes, like 14, and studying 
their reactivities.   
Conclusion 
In conclusion, a regioselective gold-catalyzed protocol for the amination of 
arenes has been developed. As phthalimides can be easily converted into free amines, 
a direct route for regioselectively synthesizing aniline derivatives has been achieved. 
Future work will focus on mechanistic studies, the lowering of the arene concentration 
and the further enhancement of the regioselectivity by shutting off the uncatalyzed 
background reactions.  The accomplishment of these aims will allow for the 
application of this reaction to the synthesis of a variety of high-value amine-containing 
compounds. 
I
N N
O O
O O
15
Me
Me
N
O
O
1 equiv PIDA
10 mol % Cy3P-Au-Cl
o-Xylene
100 oC, 24 h
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Experimental Section 
Reagents 
Substrates, including chloro(tricyclohexylphosphine)gold(I), phthalimide, and all 
arenes, were purchased from Sigma-Aldrich or Fisher Scientific. Iodobenzene 
diacetate was purchased from Acros Chemicals. Flash chromatography was performed 
using a Teledyne-Isco CombiFlash Rf with Redisep Gold silica cartridges or using a 
Biotage Isolera with SNAP Ultra silica cartridges. All reagents were stored under an 
inert atmosphere before use. 
 
Instrumentation 
GC/MS analyses were performed on an Agilent Technologies 6890 GC system with a 
5973 mass selective detector. NMR spectra were obtained using a Bruker Avance 300 
MHz spectrometer and a Varian Inova 500 MHz spectrometer. 
 
General Reaction Conditions 
A solution of phthalimide (15 mg, 0.102 mmol), iodobenzene diacetate (0.408 mmol), 
and chloro(tricyclohexylphosphine)gold(I) (0.01 mmol) in 3 mL of arene was 
assembled in a nitrogen-filled glove box. The reaction vial was then heated on an 
aluminum well-plate and allowed to magnetically stir for 12 hours at 100 °C. After 12 
hours, the reaction was allowed to cool to room temperature and was brought back 
into the nitrogen-filled glove box where an additional 0.408 mmol of iodobenzene 
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diacetate was added to the reaction vessel. The reaction was then allowed to stir for an 
additional 12 hours at 100 °C. Excess solvent was removed at reduced pressure and 
the crude reaction mixture was purified via flash chromatography with ethyl acetate 
and hexanes. The purified compound was allowed to dry in a preweighed vial 
overnight under high vacuum in order to determine product yield. Regioselectivities 
were assessed by NMR and GC/MS. In instances where NMR did not allow for 
definitive product identification, regioselectivities were determined via GC/MS 
against a set of standards. 
 
Substrates 4, 8, 10, and 11 
Regioselectivities were determined via comparison of GCMS retention times against 
independently synthesized standards as a result of overlapping signals in 1H NMR. 
Regioselectivity was obtained by integrating the area under each product’s respective 
signal in order to obtain an isomeric ratio. 
 
Oxidant and Ligand Screens (Table 1 and Table 2) 
Percent yield was calculated as a function of conversion of the starting material 
(phthalimide) into the sum of the resulting aryl coupled products (i.e. 1 - % 
phthalimide remaining). Analysis of phthalimide fragmentation patterns in the GC/MS 
suggests that the aryl-coupled product is the only phthalimide-containing species 
produced throughout the course of this reaction. Standard reaction conditions also 
 30 
proved mild enough that isolation of unreacted starting material may be achieved 
leading us to conclude that minimal, if any, decomposition of the starting material 
occurred.  This was also corroborated by the high isolated yield of 2 (90%), which is 
in line with the calculated GC yield (97%). 
Amination of o-Xylene (2)1 
 
1H NMR (300 MHz, CDCl3):  
2a: δ 2.08 (s, 3H), 2.35 (s, 3H) 
2b: δ 7.94 (dd, J = 5.4, 3.0 Hz, 2H), 7.77 (dd, J = 5.4, 3.1 Hz, 2H), 7.26 (d, J = 7.5 Hz, 
1H), 7.17 (s, 1H) 7.14 (d, J = 8.1 Hz, 1H), 2.31 (s, 6H) 
*Regioselectivity determined by comparison of peaks at 2.08 ppm and 2.31 ppm 
MS (m/z): calculated for C16H13NO2 = 251.095, observed 251.100 
 
N
O
O
N
O
O
2a 2b
2a:2b = 1:30
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Spectrum 1: 1H NMR of 2 
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 Spectrum 1.1: GC/MS of 2 
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Figure 2: Amination of Anisole (3)1,2 
 
1H NMR (300 MHz, CDCl3):  
3a: δ 7.87 (dd, J = 5.5, 3.1 Hz, 2H), 7.41 – 7.47 (m, 1H), 7.25 - 7.18 (m, 1H), 7.07 – 
7.11 (m, 1H), 3.80 (s, 1H).  
3b: δ 7.95 (dd, J = 5.5, 3.1 Hz, 2H), 7.78 (dd, J = 5.5, 3.0 Hz, 2H), 7.34 (d, J = 9.2 Hz, 
2H), 7.03 (d, J  = 9.2 Hz, 2H), 3.85 (s, 3H). 
 
MS (m/z): calculated for C15H11NO2 = 253.074, observed 253.100 
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Spectrum 2: 1H NMR of 3 
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Spectrum 2.1: GC/MS of 3 
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Amination of Toluene (4)1 
 
1H NMR (300 MHz, CDCl3):  
 
4a: δ 7.24 (m, 6H), 2.14 (s, 3H) 
4b: δ 7.24 (m, 6H), 2.35 (s, 3H) 
4c: δ 7.85 – 7.90 (m,  2H), 7.69 – 7.74 (m 2H), 7.24 (m, 6H), 2.34 (s, 3H),  
 
MS (m/z): calculated for C15H11NO2 = 237.079, observed 237.100 
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Spectrum 3: 1H NMR of 4 
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Spectrum 3.1: GC/MS of 4 
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Amination of Fluorobenzene (5)1 
 
1H NMR (300 MHz, CDCl3):  
δ 7.96 (dd, J = 5.4, 3.1 Hz, 2H), 7.80 (dd, J = 5.4, 3.1 Hz, 2H), 7.43 (dd, J = 8.5, 4.6 
Hz, 2H), 7.17 (t, J = 8.4 Hz, 2H). 
 
19F NMR (282 MHz, CDCl3):  
5a: δ -118.70 (d, J = 10.1 Hz) 
5b: δ -113.03 (tt, J = 8.3, 4.7 Hz) 
5c: δ -111.15 (q, J = 8.2 Hz) 
MS (m/z): calculated for C14H8FNO2 = 241.054, observed 241.000 
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Spectrum 4: 1H NMR of 5 
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Spectrum 4.1: 13C NMR of 5 
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Spectrum 4.2: GC/MS of 5 
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Amination of Chlorobenzene (6)1 
 
1H NMR (300 MHz, CDCl3):  
6: δ 7.95 (dd, J = 5.4, 2.9 Hz, 2H), 7.80 (dd, J = 5.4, 2.9 Hz, 2H), 7.47 (d, J = 8.8 Hz, 
2H), 7.40 (d, J = 8.8 Hz, 2H). 
 
MS (m/z): calculated for C14H8ClNO2 = 257.024, observed 257.000 
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Spectrum 5: 1H NMR of 6 
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Spectrum 5.1: GC/MS of 6 
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Amination of Bromobenzene (7)1* 
 
Isolated: 
1H NMR (300 MHz, CDCl3):  
7a: Observed by GC-MS but is not detected by NMR 
7b: δ 7.53 (m, 2 H), 7.40 (m, 2H) 
7c: δ 7.95 (m, 2H ), 7.80 (m, 2H), 7.63 (dt, J = 8.9 Hz, 4.3 Hz, 2H), 7.35 (dt, 8.9 Hz, 
4.1 Hz, 2H) 
 
MS (m/z): calculated for C14H8BrNO2 = 300.974, observed 301.000 
 
*Reference corresponds to major isomer 
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Spectrum 6: 1H NMR of 7 
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Spectrum 6.1: GC/MS of 7 
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Amination of Iodobenzene (8) 
 
 
 
1H NMR (300 MHz, CDCl3): 
 
8a (distinguishable): δ 7.74 (dd, J = 8.1 Hz, 1.3 Hz, 1H), 7.45 (dd, J = 8.1 Hz, 1.3 
Hz, 1H) 
8b (distinguishable): δ 7.21 – 7.24 (d,  J = 8.7 Hz, 2H) 
Not Classifiable: δ 7.92 – 7.99 (m, 3H), 7.79 – 7.86 (m, 5H) 
 
13C NMR (75 MHz, CDCl3):  
 
δ 166.86, 166.83, 138.25, 137.07, 135.25, 134.61, 134.58, 132.76, 131.60, 131.53, 
131.44, 130.46, 128.12, 125.80, 123.90, 123.87, 93.68, 93.28 
 
 
 
 
MS (m/z): calculated for C14H8INO2 = 349.127, observed 349.000 
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Spectrum 7: 1H NMR of 8 
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Spectrum 7.1: 13C NMR of 8 
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Spectrum 7.2: GC/MS of 8  
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Amination of Dichlorobenzene (9)1 
 
1H NMR (300 MHz, CDCl3):  
9a: δ 7.86 (dd, J = 5.6, 3.2 Hz 2H), 7.76 (dd, J = 5.6, 3.1 Hz, 2H), 7.28 – 7.29 (m 1H). 
 
9b: δ 7.97 (dd, J = 5.3, 3.1 Hz, 2H), 7.81 (dd, J = 5.5, 3.1 Hz, 2H), , 7.63 (d, J = 2.4 
Hz, 1H), 7.57 (d, J = 8.6 Hz, 1H), 7.37 (dd, J = 8.6, 2.5 Hz, 1H),  
 
MS (m/z): calculated for C14H7Cl2NO2 = 290.985, observed 291.000 
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Spectrum 8: 1H NMR of 9 
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
f1
 (
pp
m
)
-5
.0
E
+0
8
0.
0E
+0
0
5.
0E
+0
8
1.
0E
+0
9
1.
5E
+0
9
2.
0E
+0
9
2.
5E
+0
9
3.
0E
+0
9
3.
5E
+0
9
4.
0E
+0
9
4.
5E
+0
9
5.
0E
+0
9
0.16
1.00
0.98
0.90
0.53
2.02
0.51
2.02
7.25 CDCl3
7.28
7.29
7.34
7.35
7.36
7.37
7.38
7.55
7.58
7.62
7.63
7.74
7.75
7.76
7.77
7.78
7.80
7.81
7.81
7.82
7.85
7.86
7.87
7.88
7.94
7.95
7.96
7.97
7.
0
7.
5
8.
0
f1
 (p
pm
)
0.
0E
+
00
1.
0E
+
08
2.
0E
+
08
3.
0E
+
08
4.
0E
+
08
5.
0E
+
08
 55 
Spectrum 8.1: GC/MS of 9 
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Amination of m-Xylene (10)3 
 
 
1H NMR (300 MHz, CDCl3):  
δ 7.92 – 7.97 (m, 2H), 7.75 – 7.81 (m, 3H), 6.99 – 7.19 (m, 6H), 2.37 (s, 3H), 2.16 (s, 
3H). 
 
MS (m/z): calculated for C16H13NO2 = 251.095, observed 251.100 
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Spectrum 9: 1H NMR of 10 
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Spectrum 9.1: GC/MS of 10 
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Amination of Benzylchloride (11) 
 
 
1H NMR (300 MHz, CDCl3): 
 
δ 8.12 (d, J = 7.8 Hz, 2H11c +1H11a), 7.94 – 7.99 (m, 5H), 7.79 – 7.84 (m, 5H), 7.36 – 
7.64 (m, 14H), 7.27 – 7.30 (m, 1H), 4.64 (s, 2H), 4.63 (s, 1H), 4.54 (s, 1H) 
 
13C NMR (75 MHz, CDCl3):  
 
δ 167.29, 167.12, 138.56, 135.62, 134.52, 133.78, 131.90, 131.66, 130.74, 130.61, 
129.79, 129.74, 129.68, 129.48, 129.34, 128.52, 128.14, 126.69, 126.55, 126.40, 
123.98, 123.84, 45.55, 42.90 
 
 
 
 
MS (m/z): calculated for C15H10ClNO2 = 271.040, observed 271.000 
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Spectrum 10: 1H NMR of 11 
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Spectrum 10.1: 13C NMR of 11 
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Spectrum 10.2: GC/MS of 11 
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Amination of Phenetole (12) 
 
1H NMR (500 MHz, CDCl3):  
12a: δ 7.93 (dd, J = 5.6, 2.8 Hz, 2Ha + 2Hb), 7.76 – 7.78 (m, 2Ha + 2Hb), 7.40 (td, J = 
7.8, 1.7 Hz 2H), 7.24 (d, 1.6 Hz, 1H), 6.99 – 7.06 (m, 2H)  4.05 – 4.10 (m, 2Ha + 2Hb), 
1.27 (t, 7.0 Hz, 3H) 
 
12b: δ 7.93 (dd, J = 5.6, 2.8 Hz, 2Ha + 2Hb), 7.76 – 7.78 (m, 2Ha + 2Hb), 7.30 (dd, 6.1, 
2.1 Hz, 4H), 7.00 (dd, 6.0, 2.2 Hz, 2H)  (4.05 – 4.10 (m, 2Ha + 2Hb), 1.45 (t, 6.8 Hz, 
3H) 
13C NMR (125 MHz, CDCl3): 
12a (distinguishable): δ 167.38, 154.77, 64.24, 14.62 
12b (distinguishable): δ 167.59, 158.64, 134.28, 63.73, 14.79 
Aromatic Signals: 134.28, 134.06, 132.26, 131.83, 130.54, 129.93, 127.90, 124.06, 
123.65, 123.60, 120.71, 114.99, 113.14, 77.26, 77.21, 77.01, 76.76,. 
MS (m/z): calculated for C16H13NO3 = 267.090, observed 267.100 
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Spectrum 11: 1H NMR of 12 
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Spectrum 11.1: 13C NMR of 12 
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Spectrum 11.2: GC/MS of 12 
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Amination of Benzene (13) 
 
1H NMR (300 MHz, CDCl3):  
13: δ 7.88 (dd, J = 5.4, 3.1 Hz, 2H), 7.72 (dd, J = 5.4, 3.0 Hz, 2H), 7.48 - 7.40 (m, 
2H), 7.40 - 7.29 (m, 3H). 
 
MS (m/z): calculated for C14H9NO2 = 223.063, observed 223.070 
N
O
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Spectrum 12: 1H NMR of 13 
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Spectrum 12.1: GC/MS of 13 
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Manuscript 2 
Regioselective C–H Bond Amination by Aminoiodanes 
Abstract 
A new approach for the direct amination of 2-phenylpyridine derivatives using a 
diphthalimide-iodane and copper triflate has been developed. A series of different 2-
phenylpyridine derivatives were aminated with yields up to 88%. Mechanistic 
investigations indicate that the reaction proceeds via a copper-mediated single electron 
transfer. 
Introduction 
Over the past two decades advances in transition metal catalyzed C–H 
functionalization have provided efficient strategies for the construction of C–C and C–
heteroatom bonds.1 During this time an extensive amount of effort has been deovted to 
the development of novel methodologies for the construction of C–N bonds, as they 
are ubiquitous in pharmaceuticals and other high value molecules. However, synthetic 
routes for the direct amination of the C–H bonds of arenes are relatively rare.2  Recent 
examples involve the addition of nitrene intermediates into allylic and benzylic C–H 
bonds,3 though methods involving radical intermediates have also been investigated.4,5 
Most of the metal-mediated directed aminations involve late transition metal catalysts, 
such as palladium or  ruthenium,6 though recently, efforts to discover highly efficient, 
economical, and environmentally benign methods for C–N bond formation have led to 
the development of copper-mediated C–H aminations.7,8 Notably, Yu reported a C–N 
bond formation process using stoichiometric copper acetate,2b and Nicholas reported a 
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copper-catalyzed C–N bond formation process; however, this method required harsh 
conditions.9a Likewise, Li  reported the copper-catalyzed dual C–H/N–H cross-
coupling of 2-phenylpyridine with acetanilide.9b 
 Recently, we and both Chang and Antonchick simultaneously developed an 
I(III)-mediated intermolecular oxidative C–N bond formation processes for 
synthesizing anilines by a formal tandem C-H/N-H activation. Though these reactions 
provided high yields of amination products, the radical mechanism produced mixtures 
of regiomeric products for mono-subsituted arene substrates such as toluene (Scheme 
1).2d,2e,10 Subsequently, Hartwig reported a related palladium-catalyzed amination 
reaction that enhanced the regioselectivity, though both meta and para aminated 
products were observed for mono-substituted substrates.11 To remedy the 
regioselectivity issues associated with our metal-free protocol, we proposed to develop 
an I(III)-mediated reaction that achieved regioselectivity via a metal-mediated C–H 
activation with a substrate containing a Lewis base directing group.2d 
 
 
 
 
Scheme 1 Amination of arenes in the absence of a transition metal catalyst 
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Results and Discussion  
During the course of our previous investigations, we also became interested in 
the synthesis of new iodane and iodonium reagents containing I–N bonds that could be 
used as C–H aminating agents. Recently, Muñiz reported several novel hypervalent 
iodine(III) reagents for metal-free intermolecular allylic amination and diamination of 
alkenes.12 Furthermore, diaryliodonium salts had been used by the Sanford group to 
arylate C–H bonds in the presence of catalytic palladium13 and by the Gaunt group to 
arylate C–H bonds in the presence of catalytic copper.14 Consequently, we synthesized 
phenyl(diphthalimido)- l3-iodane (3) by ligand exchange from 
iodobenzenebis(trifluoroacetate), PIFA, using a relatively simple ligand exchange 
reaction.15 We also successfully synthesized a saccharin-derived iodane (4) and the 
phthalimide-iodonium salt (5) by modifying a route for synthesizing diaryliodonium 
salts from in situ-generated iodosobenzene (Scheme 2).16 
 The new iodanes and the iodonium salt were subjected to a variety of reaction 
conditions mediated by palladium or copper with 2-arylpyridine substrates. We 
hypothesized that the I(III) species would react as an electrophilic amine, and that 
regioselective metalation of the ortho Caryl–H would create a nucleophilic carbon.   
Though this initial hypothesis proved to be incorrect, we discovered a novel method to 
selectively aminate 2-phenylpyridines using iodanes such as 3, the results of which are 
presented herein. 
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Scheme 2 Synthesis of imide-substituted iodanes and an iodonium salt 
 As a control, we began by heating a solution of phthalimide, 2-phenylpyridine 
(6), and iodobenzene diacetate (PIDA) in acetonitrile using microwave irradiation and 
determined that PIDA was not able to directly aminate the pyridine derivative. As a 
result, the addition of catalytic palladium, along with PIDA or PIFA, was also 
explored. While modest amination was observed, palladium catalysis did not facilitate 
amination with acceptable yields.  Interestingly, the use of the iodane oxidant (3) 
provided the desired amination product (7), while the iodonium oxidant (5) 
exclusively provided the arylated product (8).  Consequently, we concluded that the 
iodane structure apparently favoured C–N bond formation, while the iodonium 
favoured C–C bond formation.  The reason for this trend is not readily apparent and 
will be the subject of future studies. As a result, we elected to screen copper catalysts 
and discovered that copper(II) triflate showed higher amounts of amination products 
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when compared to the previously successful experiment with palladium acetate, albeit 
at a higher catalyst loading (Table 1, entry 2).  
 The reactions were sluggish, even at 145 °C, so as a compromise, we elected to 
increase the catalyst loading to 1 equiv.  Such a consideration is only possible when 
dealing with affordable and non-toxic metals such as copper, as opposed to precious 
metals, like palladium.  
 
  
 
 
Scheme 3 Palladium catalyzed reactions of 3 and 5 
Further optimization indicated that Cu(OTf)2 was the preferred copper salt and 
that dichlorethane (DCE) was the preferred solvent (See supporting information). 
Cu(OAc)2 and CuCl2 provided low yeilds of 10 along with acetylated and chlorinated 
by-products (Table 1, entries 8 and 9). When optimizing the stoichiometry necessary 
for the iodane, an interesting pattern was observed. Since the I(III) species acted as 
both the nitrogen source and the oxidant in reactions containing substoichiometric 
Cu(OTf)2, 3 had to be used in excess.  However, when reactions containing 
stoichiometric Cu(OTf)2, were run with 1 equiv of 3, lower yields were also observed 
(entry 6), so the excess iodane reagent was determined to be optimal.  
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Optimized conditions required heating the iodane (3), the 2-arylpyridine 
substrate (9) and 1 equiv of copper triflate in dichloroethane at 80 °C for 48 h (entry 
5). Amination was exclusively observed at the ortho position, relative to the pyridine 
substituent to yield 10, and no arylated products (e.g. 8) were observed.  The presence 
of the iodane was crucial for the reactivity of the system, as reactions employing both 
stoichiometric copper and phtalimide produced only trace amounts of 10 (entry 7). It 
is also should be noted that freshly prepared iodane (3) exhibited higher yields than 
batches that had been stored under air at room temperature. 
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Entry Cu reagent (loading) Iodane (3) loading Yield (%)[b] 
1 None 2.5 equiv 0 
2 Cu(OTf)2  (25 mol%) 2.5 equiv 63[c] 
3 Cu(OTf)2  (25 mol%) 1 equiv 47[c] 
4 Cu(OTf)2  (0.5 equiv) 2.5 equiv 71[c] 
5 Cu(OTf)2  (1.0 equiv) 2.5 equiv 88[c] 
6 Cu(OTf)2  (1.0 equiv) 1 equiv 80[c] 
7 Cu(OTf)2  (1.0 equiv) None[d] 2 
8 Cu(OAc)2 (1.0 equiv) 2.5 equiv 12 
9 CuCl2 (1.0 equiv) 2.5 equiv 5 
[a] 
General reaction conditions: 9 (0.146 mmol), 3 (0.365 mmol), catalyst (0.25-1 equiv) and DCE (4 mL), heated in avial in an 
oil bathfor 48 h. [b] GC yield.  [c] Yield of isolated products after column chromatography.  [d] This reaction contained 1 equiv 
phthalimide. 
Table 1 Lead Reaction Discoverya 
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a Isolated yields following flash chromatography. 
Table 2 Substrate scopea 
A variety of 2-phenylpyridine substrates could be aminated using the optimal 
reaction conditions (Table 2). First, substrates containing different phenyl-substituted 
groups were screened. 4–Tolylpyridine (10) showed a comparable yield to 
unsubstituted 2-phenylpyridine (7); however, substrates having additional electron 
density, such as the 4-methoxy derivative (12), showed a drop in yield.  Additionally, 
it appears that the central dihedral angle of the biaryl substrate may also play a part in 
determining the substrate’s reactivity, as benzo[h]quinoline, a substrate commonly 
employed in C–H activation reactions, produced only trace yields of the aminated 
product (13).  Substitution on the pyridine ring of the substrate did not appear to 
dramatically affect the reaction. Fluorination of the pyridine directing group did not 
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dramatically alter the yield of the amination, but fluorination of the phenyl ring caused 
the yield to drop (compare 7, 14 and 18).  Additionally, the amination reaction 
proceeded with the saccharin iodane (4), to yield the expected aminated product 
(20).To elucidate the reaction mechanism, competition studies were conducted using 
an equimolar mixture of two different pyridine substrates in the lead reaction. In each 
case, amination of the more electron rich arene was favored over the electron poor 
arene.  
 
 
Entry R1 
(Py-Ar1-H) 
R2 
(Py-Ar2-H) 
X 
Py-Ar1-NPhth 
X 
Py-Ar2-NPhth 
1 H Me 42 58 
2 H F 92 8 
3 Me F 94 6 
a Mole fractions determined by GC 
Table 3 Competition Reactionsa 
 The kinetic isotope effect was also studied using an intramolecular competition 
between a C–H bond and C–D bond in 2-phenylpyridine. The observed KIE of 1.15 
indicates that C-H bond cleavage was not involved in the rate-determining step.  This 
rules out the possibility of a metal-mediated C–H activation step via oxidative 
addition, sigma-bond metathesis, or concerted metalation-deprotonation, where 
significant isotope effects are usually observed. Additionally, the substrate scope 
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(Table 2), and the competition studies (Table 3) indicate that the reaction favors 
electron rich arenes, which could be easily oxidized.  Thus, we propose a pathway 
mediated by a radical cation (23) to explain the data (Scheme 4).2b 
 
 
 
 
 
Scheme 4 Proposed mechanism for the regioselectiveamination 
 First, copper triflate reacts with the iodane (3) to generate a copper-
phthalimide species (21) and the iodonium (5). We have detected the formation of 5 
via mass spectrometry of crude reaction mixtures, and we have independently 
synthesized and characterized it (Scheme 2). Thus, we propose that 21 reacts with 2-
phenylpyridine (6) to generate a complex having Cu(II) coordinated to the pyridine 
substrate (22). A single electron transfer (SET) from the aryl ring to the coordinated 
Cu(II) generates the radical cation intermediate (23). Homolytic cleavage of the Cu–N 
bond and subsequent intramolecular anion transfer from the Cu(I) intermediate 
generates the ortho-aminated product (7). Competition studies show that the reaction 
is favored when an electron donating group is present on the aryl ring, and the SET 
from an aryl ring containing an electron-donating group should be faster than that 
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from an aryl ring containing an electron withdrawing group. We propose that SET is 
the rate-limiting step in this reaction.  
Conclusion 
 In conclusion, we have developed a novel, useful and economical process for 
the direct amination of 2-phenylpyridine derivatives. This process requires cheap and 
commercially available copper triflate and works for a variety of different 2-
phenylpyridine derivatives. Additionally, the process also works with a bis-saccharin 
iodane. Future endeavors aim to synthesize additional novel iodanes that contain I–N 
bonds in order to further develop this and other amination processes. 
 This work was supported by the National Science Foundation (CAREER 
0847222), and the National Institutes of Health (NIGMS, 1R15GM097708-01). 
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Experimental Section 
Substrates, Reagents and Catalysts.  
Potassium phthalimide, saccharin, sodium methoxide, (PIFA) Phenyliodine 
bis(trifluoroacetate),  (PIDA) Iodobenzene diacetate, methanol, (ACN) acetonitrile, 
(DCM) dichloromethane, (DCE) dichloroethane, copper triflate, palladium acetate and 
other copper catalysts were purchased from Sigma Aldrich and Fisher Scientific. Flash 
chromatography was performed on Silicycle silica gel (60Å, 40-63 µm).  All reagents 
were stored under an inert atmosphere before use. 
 
Preparation of 2- arylpyridine derivatives by literature procedures. 
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Substrates 6, 9 and 9f  were purchased from Sigma Aldrich. The other remaining 
substrates (9a, 9b, 9c, 9d, 9g and 9h) were prepared via Suzuki coupling using a 
known procedure.1 Substrate 9e was prepared by literature procedure.2 9i was prepared 
via Suzuki coupling using a literature procedure.3 Substrate 6-d  was prepared by a 
known procedure.4 
 
Instrumentation 
Microwave reactions were carried out in a CEM Discover microwave.  Flash 
chromatography was performed using CombiFlash® Rf 200. GC/MS analysis was 
carried out on an Agilent Technologies 6890 GC system fixed with a 5973 mass 
selective detector. NMR spectrum were acquired using a Bruker Avance 300MHz 
spectrometer. 
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Synthesis of phenyliodine(III) bis(phthalimidate) Iodane (3) 
A mixture of (4.5 g, 1.04 mmol) phenyliodine(III) 
bis(trifluoroacetate)  and  potassium phthalimide (3.7 g, 2.0 mmol ) 
in 100 mL of acetonitrile was  stirred at 40 0C in an oil bath for 12 
h. The off white precipitate was collected, washed with acetonitrile 
and dried under vaccum to obtain (3.6 g, 70 %) of the phenyliodine 
(III) bis(phthalimidate), Iodane 3. The NMR matched with the one 
published in literature.5  
1H NMR (300 MHz, (CD3)2SO): 7.84 (s, 5H), 7.76 (s, 3H), 7.69 – 7.64 (m, 1H), 7.53 
– 7.32 (m, 3H), 7.21 (d, J = 7.8 Hz, 1H). 
13C NMR (75 MHz, (CD3)2SO):  δ 169.21, 137.08, 134.29, 132.57, 130.64, 127.67, 
122.90. 
 
LRMS EI (m/z): [M+] calc’d for C14H9INO2 [M–Phthalimidate] + 349.9672, 349.1 
observed m/z 
Synthesis of sodium-saccharin 
In a dry round bottom flask, a mixture of saccharin (0.25 g, 1.36 
mmol) and sodium methoxide (0.073 g, 1.36 mmol) in 10 mL of 
methanol under nitrogen atmosphere was refluxed for 25 minutes in 
an oil bath. After the reflux, the flask was allowed to cool and then the excess solvent 
was removed under pressure to get white solid product. (0.26 g, 92.83 %) 
LRMS EI (m/z): [M+] calc’d for C7H4NNa3O3S   205.1663, observed 206.0 m/z. 
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Synthesis of phenyliodine(III) bis(saccharin)Iodane (4) 
 A mixture of (0.27  g, 0.633 mmol) phenyliodine(III) bis(trifluoroacetate)  and  
sodium saccharin  (0.26  g, 1.267  mmol) in 100 mL of 
acetonitrile was stirred at 40 0C in an oil bath for 12 h. The 
white precipitate was collected, washed with acetonitrile and 
dried under vaccum to obtain (0.234 g, 65%) of the 
phenyliodine(III) bis(saccharin) iodane 4.   
1H NMR (300 MHz, (CD3)2SO): δ 8.00 – 7.95 (m, 1H), 7.68 – 7.64 (m, 3H), 7.62 – 
7.57 (m, 9H). 
13C NMR (75 MHz, (CD3)2SO): δ 166.80, 144.13, 133.62, 130.43, 130.30, 129.87, 
127.85, 125.35, 121.36, 117.97, 116.95. 
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Spectrum 1. 1H NMR of 4 
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Spectrum 1.1. 13C NMR of 4 
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Synthesis of Iodonium Triflate salt (5) 
 A mixture of m-chloroperoxybenzoic acid (0.25 g, 1.495 mmol) 
and iodobenzene (0.3 g, 1.495 mmol) were dissolved in 2 mL 
dichloromethane in a vial and stirred at room temperature for 5 
minutes.  Phathalimide (0.2 g, 1.359 mmol) was added to this vial and the vial was 
cooled to 0 0C. This was followed by dropwise addition of triflic acid (0.6 g, 4.078 
mmol) to the reaction mixture to give a colored solution. The reaction mixture was 
later stirred for at room temperature for 30 mins and subsequently concentrated under  
vacuum. Diethyl ether (2 mL) was added to the vial and the mixture was stirred at 
room temperature for 10 mins to precipitate out an off-white solid. The solid was 
filtered off, washed with ether and dried under vacuum to obtain (0.42 g, 61 %) of 5. 
1H NMR (300 MHz, (CD3)2SO): δ 8.24 (d, J = 7.8 Hz, 2H), 8.00 (d, J = 8.2 Hz, 2H), 
7.90 (d, J = 8.2 Hz, 2H), 7.67 (t, J = 7.4 Hz, 1H), 7.53 (t, J = 7.7 Hz, 2H) 
13C NMR (75 MHz, (CD3)2SO): δ 169.22, 140.33, 136.74, 135.14, 134.31, 132.07, 
131.74, 127.04, 122.91, 122.77, 118.50, 116.77, 115.95, 114.23, 100.21 
LRMS EI (m/z): [M+] calc’d for C14H9INO2 [M–TfO-] + 349.9672, 349.1 observed 
m/z. 
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Spectrum 2. 1H NMR of 5 
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Spectrum 2.1. 13C NMR of Compound 5 
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Initial Optimization Studies 
 
N
R
R = H, 6
R = Me, 9
I N
O
O 23
+
Conditions
N
R
R = H, 7
R = Me, 10
NPhth
Entry R Conditions Yield 7/10 
(%) 
1 H 3 (1 equiv), PIDA (2.5 equiv) , ACN, 145 0C  (MW) , 3h - 
2 H 3 (1 equiv), PIFA (2.5 equiv) , ACN , 145 0C  (MW) , 3h - 
3 H 3 (1 equiv), Pd(OAc)2 (25 mol %) , ACN , 145 0C  (MW) , 
3h 
13 
4 H 3 (1 equiv), Cu(OTf)2 (25 mol %) , DCM, 70 0C , 5 h 9 
5 H 3 (2.5 equiv), Cu(OTf)2 (25 mol %) , DCM, 70 0C  , 48 h 63 
6 H 3 (1 equiv), Cu(OTf)2 (1 equiv) , DCM, 70 0C  , 48 h 80 
7 H 3 (2.5 equiv), Cu(OTf)2 (1 equiv) , DCE, 70 0C  , 48 h 87 
8 Me 3 (2.5 equiv), CuF2 (1 equiv) , DCE, 80 0C  , 48 h 5 
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Table 1.  Initial Optimization Studies 
General procedure for Substrate Library 
To a solution of the appropriate 2-arylpyridine  (1 equiv) in 1,2-dichloroethane (4 mL) 
was added the appropriate iodane (2.5 equiv) and Cu(OTf)2 (1 equiv). The reaction 
was stirred for the 48 h at 80 o C in an oil bath before dilution with DCM (30 mL) and 
washing with saturated sodium bicarbonate solution (30 mL). The aqueous phase was 
extracted further with DCM (25 mL) and the combined organic layers were dried over 
sodium sulphate and the excess solvent was removed under pressure. The crude 
residue was purified by flash column chromatography to obtain the pure aminated 
product. 
This general procedure was followed for synthesis of 7, 10, 11, 12, 14, 15, 16, 17, 18, 
19 and 20 
9 Me 3 (2.5 equiv), CuCl (1 equiv) , DCE, 80 0C  , 48 h 6 
10 Me 3 (2.5 equiv), CuBr (1 equiv) , DCE, 80 0C  , 48 h 9 
11 Me 3 (2.5 equiv), CuBr2 (1 equiv) , DCE, 80 0C  , 48 h 5 
12 Me 3 (2.5 equiv), CuSO4 (1 equiv) , DCE, 80 0C  , 48 h 5 
13 Me 3 (2.5 equiv), Cu(NO3)2 (1 equiv) , DCE, 80 0C  , 48 h 5 
14 Me 3 (2.5 equiv), CuCN (1 equiv) , DCE, 80 0C  , 48 h 5 
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Synthesis of 2-(2-(pyridin-2-yl)phenyl)isoindoline-1,3-dione  (7) 
Substrate 6 was subjected to the general procedure. After 
purification by column chromatography, 7 was obtained (91 mg, 
87%). The NMR matched with the one published in literature.6 
 Rf -Value:  Hexane/Ethyl acetate (3:2 v/v) = 0.29. 
1H NMR (300 MHz, CDCl3): δ 8.29 (ddd, J = 4.9, 1.8, 0.9 Hz, 1H), 7.84 (dd, J = 5.4, 
3.1 Hz, 2H), 7.76 – 7.71 (m, 3H), 7.65 (td, J = 7.9, 2.1 Hz, 1H), 7.59-7.54 (m, 2H), 
7.47 (dt, J = 7.9, 0.9 Hz, 1H), 7.44-7.40 (m, 1H), 7.07 (ddd, J = 7.6, 4.9, 1.2 Hz, 1H). 
 LRMS EI (m/z): [M+] calc’d for C19H12 N2O2   300.0899, 300.11 observed m/z. 
 
Synthesis of 2-(5-methyl-2-(pyridin-2-yl)phenyl)isoindoline-1,3-dione  (10) 
Substrate 9 was subjected to the general procedure. After 
purification by column chromatography, 10 was obtained (40.2 
mg, 88 %). The NMR matched with the one published in 
literature.6 
 Rf -Value:  Hexane/Ethyl acetate (7:3 v/v) = 0.29. 
1H NMR (300 MHz, CDCl3): δ 8.26 (ddd, J = 4.8, 1.9, 1.0 Hz, 1H), 7.84 (dd, J = 5.5, 
3.1 Hz, 2H), 7.72 (dd, J = 5.5, 3.1 Hz, 2H), 7.62 (td, J = 7.8, 1.7 Hz, 2H), 7.48 – 7.35 
(m, 2H), 7.22 (d, J = 1.1 Hz, 1H),  7.03 (ddd, J = 7.5, 4.9, 1.2 Hz, 1H), 2.46 (s, 3H). 
LRMS EI (m/z): [M+] calc’d for C20H14 N2O2   314.1055, 314.19 observed m/z. 
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Synthesis of 2-(3-methyl-2-(pyridin-2-yl)phenyl)isoindoline-1,3-dione (11) 
Substrate 9a was subjected to the general procedure. After 
purification by column chromatography, 11 was obtained (13.1 
mg, 40 %). The NMR matched with the one published in 
literature.6 
 Rf -Value:  Hexane/Ethyl acetate (7:3 v/v) = 0.3. 
1H NMR (300 MHz, CDCl3): δ 8.38 (ddd, J = 4.8, 1.7, 1.0 Hz, 1H), 7.83-7.75 (m, 
4H), 7.68 (td, J = 7.7, 1.8 Hz, 1H), 7.5 -7.45 (m, 2H), 7.37-7.33 (m, 1H), 7.31 (d, J = 
7.8 Hz, 1H), 7.14 (ddd, J = 7.6, 4.9, 1.0 Hz, 1H), 2.06 (s, 3H) 
LRMS EI (m/z): [M+] calc’d for C20H14 N2O2   314.1055, 314.19 observed m/z. 
 
Synthesis of 2-(5-methoxy-2-(pyridin-2-yl)phenyl)isoindoline-1,3-dione (12) 
Substrate 9b was subjected to the general procedure. After 
purification by column chromatography, 12 was obtained (22.1 
mg, 50%). The NMR matched with the one published in literature. 
6 
 Rf -Value:  Hexane/Ethyl acetate (7:3v/v) = 0.24. 
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1H NMR (300 MHz, CDCl3): δ 8.49 (d, J = 4.9 Hz, 1H), 8.33 – 8.29 (m, 1H), 8.04 – 
7.67 (m, 4H), 7.60 – 7.48 (m, 2H), 7.14 (d, J = 8.4 Hz, 1H), 7.05 – 6.99 (m, 2H), 3.82 
(s, 3H). 
LRMS EI (m/z): [M+] calc’d for C20H14 N2O3   330.1005, observed 330 m/z. 
 
Synthesis of 2-(5-fluoro-2-(pyridin-2-yl)phenyl)isoindoline-1,3-dione (14) 
Substrate 9d was subjected to the general procedure. After 
purification by column chromatography, 14 was obtained (16 mg, 37 
%). The NMR matched with the one published in literature.6 
 Rf -Value:  Hexane/Ethyl acetate (7:3 v/v) = 0.23 
1H NMR (300 MHz, CDCl3): δ 8.28 (ddd, J = 4.9, 1.8, 0.9 Hz, 1H), 7.88 – 7.83 (m, 
2H), 7.78 – 7.61 (m, 4 H), 7.44 (dt, J = 7.9, 1.1 Hz, 1H), 7.31 (dd, J = 8.3, 2.5 Hz, 
1H), 7.17 (dd, J = 8.7, 2.6 Hz, 1H), 7.08 (ddd, J = 7.5, 4.8, 1.1 Hz, 1H).  
LRMS EI (m/z): [M+] calc’d for C19H11F N2O2   318.0805, 318.01 observed m/z. 
 
 
 
 101 
Synthesis of 2-(5-chloro-2-(pyridin-2-yl)phenyl)isoindoline-1,3-dione (15) 
Substrate 9e was subjected to the general procedure. After 
purification by column chromatography, 15 was obtained ( 106.5 
mg, 41 %). 
 Rf -Value:  Hexane/Ethyl acetate (7:3 v/v) = 0.26 
1H NMR (300 MHz, CDCl3): δ 8.27 (ddd, J = 4.8, 1.9, 0.9 Hz, 1H), 7.85 (dd, J = 5.5, 
3.1 Hz, 2H), 7.78 – 7.72 (m, 2H), 7.70 – 7.62 (m, 2H), 7.55 (dd, J = 8.3, 2.1 Hz, 1H), 
7.45 (dd, J = 7.3, 1.5 Hz, 2H), 7.08 (ddd, J = 7.7, 4.9, 1.2 Hz, 1H). 
13C NMR (75 MHz, CDCl3 ): δ 167.3, 156.0, 149.4, 137.0, 136.8, 134.9, 134.2, 131.9, 
131.4, 130.8, 130.4, 129.7, 123.7, 122.7, 122.4. 
LRMS EI (m/z): [M+] calc’d for C19H11Cl N2O2   334.0509, 334.15 observed m/z. 
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Spectrum 3. 1H NMR of 15 
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Spectrum 3.1. 13C NMR of 15 
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Synthesis of 3-(1,3-dioxoisoindolin-2-yl)-4-(pyridin-2-yl)benzaldehyde (16) 
Substrate 9f was subjected to the general procedure. After 
purification by column chromatography, 16 was obtained (69.3 
mg, 40 %).  
 Rf -Value:  Hexane/Ethyl acetate (7:3 v/v) = 0.2 
1H NMR (300 MHz, CDCl3): δ 10.11 (s, 1H), 8.35 – 8.30 (m, 1H), 8.10 (dd, J = 7.9, 
1.7 Hz, 1H), 7.95 – 7.92 (m, 2H), 7.87 (dd, J = 5.5, 3.0 Hz, 2H), 7.76 (dd, J = 5.5, 3.1 
Hz, 2H), 7.69 (dd, J = 7.7, 1.8 Hz, 1H), 7.53 (d, J = 8.0 Hz, 1H), 7.14 (ddd, J = 7.6, 
4.8, 1.2 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 190.7, 167.3, 155.8, 149.5, 143.9, 137.0, 134.3, 131.9, 
131.7, 131.4, 130.7, 130.0, 127.9, 123.8, 123.0, 122.9. 
LRMS EI (m/z): [M+] calc’d for C20H12N2O3   328.0848, 328.04 observed m/z. 
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Spectrum 4. 1H NMR of 16 
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Spectrum 4.1. 13C NMR of 16 
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Synthesis of  2-(2-(5-nitropyridin-2-yl)phenyl)isoindoline-1,3-dione (17) 
Substrate 9i was subjected to the general procedure as described 
above. After purification by column chromatography, 17 was 
obtained (36.3 mg, 27%).  
 Rf -Value:  Dichloromethane = 0.69 
1H NMR (300 MHz, CDCl3): δ 9.11 (d, J = 2.7 Hz, 1H), 8.47 (dd, J = 8.8, 2.6 Hz, 
1H), 7.87 (dd, J = 5.4, 2.9 Hz, 2H), 7.80 – 7.76 (m, 3H), 7.71 (d, J = 8.9 Hz, 1H), 7.65 
(td, J = 6.7, 1.9 Hz, 2H), 7.48 (dd, J = 7.3, 1.9 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 167.4, 162.7, 144.6, 136.3, 134.5, 134.4, 132.05, 
131.8, 131.0, 130.7, 130.4, 129.9, 129.7, 123.9, 123.6, 123.0. 
 LRMS EI (m/z): [M+] calc’d for C19H11N3O4   345.075, 345.02 observed m/z. 
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Spectrum 5. 1H NMR of 17 
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Spectrum 5.1. 13C NMR of 17 
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Synthesis of 2-(2-(5-fluoropyridin-2-yl)phenyl)isoindoline-1,3-dione (18) 
Substrate 9g was subjected to the general procedure. After 
purification by column chromatography, 18 was obtained (152.1 
mg, 83 %).  
 Rf -Value:  Hexane/Ethyl acetate (7:3 v/v) = 0.2. 
1H NMR (300 MHz, CDCl3): δ 8.14 (d, J = 2.8 Hz, 1H), 7.87 – 7.84 (m, 2H), 7.76 – 
7.73 (m, 2H), 7.69 (dd, J = 5.7, 3.4 Hz, 1H), 7.57 (dd, J = 5.7, 3.4 Hz, 2H), 7.52 – 7.47 
(m, 1H), 7.41 (dd, J = 6.0, 3.2 Hz, 1H), 7.36 (dd, J = 8.5, 2.8 Hz, 1H). 
13C NMR (75 MHz, CDCl3): δ 167.6, 153.2 (d, JC-F = 4.3 Hz), 137.6 (d, JC-F = 4.2 
Hz), 135.8 (d, JC-F = 223.7 Hz), 134.17, 132.7, 132.0, 130.3 (d, JC-F = 17.8 Hz), 129.6, 
123.9 (br), 123.8, 123.7, 123.6, 123.5. 
LRMS EI (m/z): [M+] calc’d for C19H11FN2O2   318.0805, 318.11 observed m/z. 
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Spectrum 6. 1H NMR of 18 
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Spectrum 6.1. 13C NMR of 18 
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Synthesis of 2-(2-(5-fluoropyridin-2-yl)-5-methylphenyl)isoindoline-1,3-dione (19) 
Substrate 9h was subjected to the general procedure as described 
above. After purification by column chromatography, 19 was obtained 
(66.6 mg, 34 %). 
 Rf -Value:  Dichloromethane = 0.81. 
1H NMR (300 MHz, CDCl3): δ 8.11 (d, J = 2.9 Hz, 1H), 7.87 (td, J = 5.6, 3.0 Hz, 
4H), 7.76 (td, J = 5.3, 3.0 Hz, 4H), 7.58 (d, J = 7.9 Hz, 1H), 7.37 (dd, J = 8.7, 2.6 Hz, 
2H), 7.22 (d, J = 1.8 Hz, 1H), 2.46 (s, 3H). 
13C NMR (75 MHz, CDCl3): δ 168.0, 156.7, 138.6 (d, JC-F = 210.6 Hz), 137.5, 
134.66, 134.34, 134.2 (d, JC-F = 16.2 Hz), 132.6, 132.0, 130.6 (d, JC-F = 17.3 Hz), 
130.2, 129.3, 123.7, 123.6 (br), 21.1. 
 LRMS EI (m/z): [M+] calc’d for C20H13FN2O2   332.0961, 332 observed m/z. 
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Spectrum 7. 1H NMR of Compound 19 
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Spectrum 7.1. 13C NMR of 19 
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Synthesis of 20 
Substrate 4 was subjected to the general procedure as described 
above. After purification by column chromatography, 20 was 
obtained (10.5 mg, 88 %). 
 Rf -Value:  Hexane/Ethyl acetate (7:3 v/v) = 0.14. 
1H NMR (300 MHz, CDCl3): δ 8.49 (dt, J = 4.9, 1.4 Hz, 1H), 8.07 (dd, J = 6.8, 1.7 
Hz, 1H), 7.94 – 7.81 (m, 4H), 7.70 – 7.58 (m, 5H), 7.14 (ddd, J = 6.7, 4.8, 2.1 Hz, 
1H). 
13C NMR (75 MHz, CDCl3): δ 156.3, 149.5, 141.0, 137.8, 136.4, 134.8, 134.3, 131.6, 
131.1, 131.0, 129.9, 126.0, 125.6, 123.0, 122.4, 121.2. 
 LRMS EI (m/z): [M+] calc’d for C19H11N3O4   336.0569, 336.11 observed m/z. 
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Spectrum 8. 1H NMR of 20 
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Spectrum 8.1. 13C NMR of  20 
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Kinetic Isotope Effect 
 
 
 
To a solution of 6-d  (0.0179 g, 0.114 mmol) in 1,2-dichloroethane (4 mL) was added 
the iodane 3 (0.142 g, 0.286 mmol) and Cu(OTf)2 (0.041 g, 0.114 mmol). The reaction 
mixture was stirred for 48 h at 80 oC in an oil bath. The reaction was then cooled, and 
an aliquot was removed and analyzed by GC/MS. 
GC/MS Conditions:  J & W Scientific DB-1, capillary 25.0m x 200µm x 0.33µm, 1.3 
mL/min, 40 oC, hold 0.50min, 12 oC/min to 320 oC, hold 6.0 min. 
kH/kD = 1.15 
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Competition experiment 
 
 
 
To a solution of equimolar amounts of Py-Ar1-H (1equiv) and Py-Ar2-H (1equiv) in 
1,2-dichloroethane (4 mL) was added the iodane  3 (2.5 equiv) and Cu(OTf)2 (1 
equiv). The reaction was mixture was stirred for the 48 h at 80 oC in an oil bath. The 
reaction was then cooled, and an aliquot was removed and analyzed by GC/MS 
 
[a] Mole fractions determined by GC/MS 
 
	   Py-­‐Ar1-­‐H	  
	  
R1	  
Py-­‐Ar2-­‐H	  
	  
R2	  
Py-­‐Ar1-­‐NPhth	  (%)[a]	   Py-­‐Ar2-­‐NPhth	  (%)[a]	  
1	   H	   Me	   42	   58	  
2	   H	   F	   92	   8	  
3	   Me	   F	   94	   6	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 Calibration Curve  
 
 
 
The pure product 10 was isolated by column chromatography. Known Concentrations 
in ppm for (1-100% yield) were prepared in DCE. The plot of various concentrations 
against their area under the curve from GC-MS spectrum generates the calibration 
curve.   
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Efforts Towards the Synthesis of a Molecular Probe Targeting the D2 Receptor 
 
Abstract 
Over the last several decades the dopamine receptors have been extensively targeted 
for drug development and design. Herein, a report focusing on the efforts made 
towards the development of a D2 dopamine probe will be discussed. Additionally, a 
proposed synthetic pathway that should allow for the successful isolation of the D2 
receptor from lysed cellular mixtures will be detailed. 
Introduction 
The D2 dopamine receptor is a membrane-bound protein that binds the 
neurotransmitter, dopamine, in the synaptic cleft.  In addition to its normal functions 
that are associated with cognitive reward responses, the D2 receptor is believed to be 
associated with a number of neurobehavioral disorders.1 Degradation or inhibition of 
any of the D1-D5 receptor subunits of dopamine have been linked to Parkinson’s 
disease, certain motor and hyperactivity disorders, schizophrenia, and substance abuse. 
As such, medicinal chemists have exhausted a significant amount of resources 
D2 Binding
Agonist
Streptavidin
Agonist
Covalent
LinkageSerine
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attempting to construct dopamine agonists in order to develop a new class of 
pharmaceuticals, particularly with respect to the D2 receptor family.1 It is widely 
accepted that pharmaceuticals prescribed to treat such neurological disorders must 
share the common trait of inhibiting the D2 receptor, but little is known with regards to 
the correlation between therapeutic benefit and the levels of D2 agonist selectivity.2 
Due to the fact this target is a membrane bound receptor, a crystal structure elucidating 
it’s characteristics has yet to be obtained thus making logical drug design difficult. In 
order to bridge this gap, mechanistic insight elucidating the therapeutic properties of 
D2 selective agonists needs to be more thoroughly understood.2 
 
 
 
 
 
 
Figure 1: Dopamine Receptor Structure3 
Dopamine is a membrane bound protein and is subdivided into five unique G 
protein-coupled receptors, D1-D5 (Figure 1).3-4 Amongst these five subdivisions, each 
receptor is classified under two main families: D1-like receptors and D2-like 
receptors.2 The D2 receptor is the second most abundant dopamine receptor and is 
more highly concentrated in deeper regions of the mammalian forebrain such as 
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hypothalamus, amygdala, and hippocampus.1,5 As a result, finding suitable ligands to 
serve as agonists that are capable of both crossing the blood-brain barrier and eliciting 
a biological response is often problematic. Extensive studies have been performed to 
elucidate general characteristics of D2 receptor-selective ligands. Amongst the class of 
receptor-selective ligands are isoquinoline, 2-amino-1-phenyl-2,3-dihydroindene, 
aporphine and their derivatives.1 However, molecules such as racolopride, N-
methylspiperone, and IBZM have proven to be the most beneficial when trying to 
image the dopamine receptors as they are D2 selective agonists (Figure 2). Through 
positron emission tomography and single-photon emission computer tomography the 
aforementioned molecules, once radio labeled, serve as excellent imaging probes due 
to their high binding affinity and sensitivity to competitive agonist inhibition.1  
 
Figure 2: Imaging Ligands 
Due to the high binding affinity of spiperone derivatives for the D2 receptor, 
we set out to develop a chemical probe that possessed four key characteristics: (1) The 
ideal probe must contain an agonist that will elicit a biological response; (2) after 
binding, the probe must covalently tether the probe to the target receptor; (3) the probe 
must contain a separate functionality that will allow for isolation of the receptor 
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protein; and (4) a trifunctional scaffold must be identified that can incorporate the 
previously mentioned functionalities (Scheme 1).  
Efforts Towards Proposed Probe Synthesis 
 
Scheme 1: Construction of Serine Scaffold 
The investigation began with the identification of an amino acid scaffold that 
could incorporate the three functionalities. As a result, serine was ultimately deemed 
the most appropriate, as the hydroxyl residue provided an excellent pathway for biotin 
conjugation via an ester linkage. In order to couple Boc-(L)-Ser-OH (1) to biotin, the 
serine had to first be protected on the carboxyl terminus. By subjecting 1 so a solution 
of allylbromide and Na2CO3 in DMF, 2 was produced with an excellent yield (87%) 
and flash chromatography was unnecessary after extracting the product with EtOAc.2 
Boc-(L)-Ser-O(All) (2) was then dissolved in DMF and introduced to a flask 
containing N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC), 
hydroxybenzotriazole (HOBt), diisopropylethylamine (DIPEA), and biotin (3). The 
mixture was allowed to stir uninterrupted for 24 h under a nitrogen atmosphere. Flash 
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purification provided good yields of the biotin ester (4), albeit slightly impure. An 
inseparable mixture of 4 and unreacted biotin was observed. This mixture was carried 
on to the next step without further purification.  
Boc deprotection commenced by dissolving 4 in EtOAc, cooling the solution 
to 0oC, and adding conc. HCl drop wise to the reaction mixture. Deprotection was 
deemed completed when the evolution of CO2 and ethylene gas was no longer 
observed. The biotin impurity present after the synthesis of 4 was removed by washing 
the reaction mixture containing 5 with water. The biotin impurity was extracted into 
EtOAc while the amine, 5, remained in the aqueous layer. 13C NMR indicated that 5 
was epimerized as a result of the deprotection procedure, presumably at serine’s chiral 
center, but the diastereomeric mixture was carried on without resolution. In order to 
add an additional site of functionalization, 5 was introduced to a stirred solution of 
succinic anhydride in order to afford 6. The tethered carboxylic acid will serve as a 
site of attachment for the conjugated spiperone linker 11, which was synthesized 
according to a known procedure (scheme 2).3  
 
 
 
 
 
Scheme 2: Spiperone Alkylation 
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Proposed Probe Completion 
 
 
 
 
Scheme 3: Proposed Synthesis of Target Molecule 
Introduction of the spiperone moiety has proven to be the most challenging 
aspect of the proposed synthesis. Prior attempts to directly alkylate spiperone to the 
amino acid scaffold proved to be ineffective as conditions necessary to carryout the 
substitution reaction readily hydrolyzed the linker from the serine scaffold or resulted 
in the corresponding olefin due to the elimination of bromine (Scheme 4). As a result, 
efforts were directed towards the orthogonal construction of 11 so that the resulting 
aniline functionality may be coupled directly to 6. However, aniline has proven to be 
too weak of a nucleophile and this step cannot be achieved through traditional peptide 
coupling procedures.  
 
 
Scheme 4: Hydrolysis of Molecular Probe 
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As a result, the following proposed methodology should allow for the 
successful synthesis of 14 without the worry of degradation to the serine scaffold 
(scheme 3). To combat the poor nucleophilicity of aniline, the acid chloride analog of 
6 will be synthesized from oxalyl chloride in order to afford an intermediate 
significantly more susceptible to nucleophilic attack. Once 12 has been isolated, 
removal of the allyl group on the carboxyl terminus of serine with stoichiometric Pd/C 
will give rise to 13. Drawing inspiration from a 2003 communication by the Sames 
group this free carboxyl moiety allows for the introduction of an epoxide functional 
group, for covalent tethering. The necessity for covalent linkage is due to the 
likelihood of protein denaturation during probe manipulation. In order to effectively 
remove the dopamine receptor from the cell membrane, the lipids will need to be 
dissolved through the use of detergents. This process will potentially liberate 
spiperone from the D-2 receptor, as a conformational change will alter binding 
affinity, however, a covalent linkage will allow the probe to remain tethered to the 
target molecule The desired epoxide moiety can be added to  13  via esterification with 
glycidol, affording the target molecule, 14.7 
Conclusion 
In summation, this manuscript details the efforts made towards the synthesis of 
a spiperone-based probe and a proposed synthetic route for its successful completion. 
Future work will focus on optimization and isolation of the target molecule with 
significant emphasis placed on the preservation of stereochemistry and synthesis of 
additional stereoisomers.  
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Experimental Section 
Reagents 
Substrates were purchased from Sigma-Aldrich or Fisher Scientific and used as is. 
Flash chromatography was performed using a Biotage Isolera with SNAP Ultra silica 
cartridges. 
 
Instrumentation 
GC/MS analyses were performed on an Aglient Technologies 6890 GC system with a 
5973 mass selective detector. NMR spectra were obtained using a Bruker Avance 300 
MHz spectrometer and a Varian Inova 500 MHz spectrometer. 
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Synthesis of 21 
 
Boc-L-Ser (1.00g, 4.87 mmol) is dissolved in 25 mL of DMF. Na2CO3 (1.03g, 9.75 
mmol) allyl bromide (0.46 mL, 5.37 mmol), and 0.7 mL of water is then added and 
stirred overnight. The reaction mixture is extracted into EtOAc and carried on to the 
next step without further purification (yield = 0.103 g, 89%). 
1H NMR (300 MHz, Chloroform-d)  
δ 5.91 (m, 1H), 5.81 (d, J = 8.6 Hz, 1H), 5.41 – 5.30 (m, 1H), 5.24 (dd, J = 10.5, 1.6 
Hz, 1H), 4.70 – 4.62 (m, 2H), 4.36 (dt, J = 8.4, 3.8 Hz, 1H), 3.98 (dt, J = 10.4, 4.9 Hz, 
1H), 3.91 – 3.75 (m, 2H), 1.45 (s, 9H). 
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Spectrum 1: 1H NMR of 2 
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Synthesis of 4  
 
Biotin (93 mg, 0.381 mmol) EDC (80 mg, 0.419 mmol), HOBt (57 mg, 0.419 mmol) 
and DIPEA (0.165 mL, 0.953 mmol) were dissolved in 5 mL of DMF and stirred until 
dissolved. Boc-Ser-O(All) (94 mg, 0.381 mmol) was then added to the reaction 
mixture, placed under N2 and stirred for 24 h. The crude reaction mixture was 
extracted into EtOAc and was purified via flash chromatography in 1:9 MeOH/CH2Cl2 
to afford 4 as a slightly impure oil (0.110, 89%).  
1H NMR (300 MHz, CDCl3)  
δ 7.85 (d, J = 8.2 Hz, 1H), 7.70 (d, J = 8.0 Hz, 1H), 7.40 (dt, J = 18.8, 7.1 Hz, 1H), 
6.34 (s, 1H), 5.97 – 5.80 (m, 1H), 5.64 (d, J = 8.5 Hz, 1H), 5.37 – 5.20 (m, 2H), 4.65 
(d, J = 5.0 Hz, 1H), 4.64 – 4.29 (m, 4H), 3.14 (q, J = 6.6 Hz, 1H), 2.96 – 2.86 (m, 1H), 
2.76 (d, J = 12.9 Hz, 1H), 2.32 (td, J = 7.4, 2.7 Hz, 2H), 1.75 – 1.56 (m, 3H), 1.44 (s, 
9H). 
13C NMR (75 MHz, CDCl3)  
δ 173.16, 169.73, 164.32, 155.33, 131.38, 128.21, 126.88, 125.58, 118.95, 118.12, 
110.66, 80.32, 77.50, 77.28, 77.08, 76.65, 66.34, 64.21, 62.10, 60.42, 55.52, 53.09, 
40.52, 33.58, 28.30, 28.12, 24.57 
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Spectra 2: 1H NMR of 4 
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Spectrum 2.1: 13C NMR of 4 
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Synthesis of 5 
 
To a solution of 4 in EtOAc at 0oC, 3M HCl was added drop wise. The reaction was 
monitored by TLC until consumption of the starting material was observed. The 
reaction was quenched with water and the biotin impurity that could not be removed 
during the synthesis of 4 was extracted into EtOAc. 5 was present as a colorless oil in 
the aqueous layer. This protocol led to epimerization of the chiral center. 
1H NMR (300 MHz, Methanol-d4)  
δ 7.93 (d, J = 7.3 Hz, 2H), 7.83 (d, J = 7.4 Hz, 2H), 7.60 (p, J = 7.0 Hz, 4H), 5.99 (ddt, 
J = 16.1, 10.2, 5.1 Hz, 4H), 5.47 – 5.24 (m, 9H), 4.78 (t, J = 5.7 Hz, 8H), 4.69 – 4.51 
(m, 9H), 4.46 (s, 2H), 4.21 (s, 1H), 4.12 – 3.95 (m, 3H), 3.66 (s, 2H), 3.00 (d, J = 12.3 
Hz, 3H), 2.80 (d, J = 11.2 Hz, 3H), 2.40 (dt, J = 25.9, 7.1 Hz, 6H), 1.77 (s, 2H), 1.73 – 
1.57 (m, 9H), 1.44 (dd, J = 14.9, 6.9 Hz, 7H). 
13C NMR (75 MHz, MeOD)  
δ 175.86, 174.22, 168.71, 167.77, 132.73, 132.56, 129.10, 128.60, 119.98, 119.55, 
117.96, 112.04, 68.45, 68.01, 64.46, 62.86, 62.59, 60.81, 56.93, 56.23, 53.64, 52.22, 
50.00, 49.72, 49.43, 49.15, 48.87, 48.58, 48.30, 40.87, 34.77, 34.64, 34.34, 29.76, 
29.51, 29.46, 25.93, 25.64. 
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Spectrum 3: 1H NMR of 5 
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Spectrum 3.1: 13C NMR of 5 
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Spectrum 3.2: Mass Spectrum of 5 
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Solution-Phase Synthesis of Dipeptides: A Capstone Project that Employs Key 
Techniques in an Organic Laboratory Course 
 
 
ABSTRACT 
 
A contemporary approach to the synthesis and purification of several UV-active 
dipeptides has been developed for the sophomore-level organic laboratory. This 
experiment exposes students to the important technique of solution-phase peptide 
synthesis and allows the instructor to highlight the parallel between what they are 
accomplishing in the laboratory to the advancements being made in the 
pharmaceutical industry. By illustrating the importance of protecting group strategy 
and stereochemistry preservation, while also reinforcing the various separatory and 
purification techniques learned throughout the typical laboratory course, this 
experiment serves as an excellent candidate for a capstone demonstration of the  
INTRODUCTION 
 
The second-year organic laboratory course is responsible for training a multitude 
of students across a wide variety of fields. Students enrolled in this course are not just 
those with an interest in chemistry, but rather the bulk of the course’s population is 
often composed of students majoring in other scientific disciplines such as biological 
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science, engineering, microbiology, or pharmaceutical sciences. As a result, the 
implementation of a curriculum that not only appeals to each student, but is also 
applicable to their chosen professions, is essential for maintaining an enthusiastic and 
engaged environment. Most students have been exposed to the topic of peptide 
coupling in their introductory life science courses and will continue to learn about the 
chemistry of amino acids, peptides and proteins as they progress toward their 
undergraduate science degrees. Several laboratory exercises about the synthesis of 
peptides have been described in this Journal, but, with two exception, they all rely on 
solid phase peptide synthesis techniques.1-4 While this is a powerful technology, it 
does not necessarily employ the same skill set that is taught in a typical synthetic 
laboratory. Few examples of solution-phase peptide synthesis have been published in 
chemical education literature. The examples that do exist either employ harsh reagents 
and unsafe techniques (thionyl chloride, -45 °C, benzene extractions), utilize unnatural 
amino acids, or make use of procedures that do not reflect modern solution-phase 
peptide chemistry, particularly with respect to stereochemistry preservation.5-9 In our 
opinion, the most straightforward method for solution-phase peptide synthesis that has 
been described as a laboratory exercise was published by 1989, but it involves the use 
of a rare coupling agent and chiral TLC.8 Herein, we report a multi-step synthesis of 
dipeptides that has been performed by over 400 students over the past three years.  
The pedagogy of this laboratory exercise allows students to combine multiple 
techniques that they have learned throughout a typical second-year organic laboratory 
course.  
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PEDAGOGY 
 
In the beginning of any organic laboratory course students are introduced to the 
basic techniques associated with organic synthesis. This typically includes techniques 
such as separatory extraction, pH manipulation, vacuum filtration, rotary evaporation 
etc. As they progress through the course the students are expected to become more 
confident with these skills. By the end of the one or two-semester laboratory course 
the students should be able to successfully synthesize, purify, and analyze moderately 
complex small molecules. The procedure detailed herein combines the skills students 
have learned throughout a typical organic laboratory course and concludes with the 
isolation and characterization of a bioorganic molecule made from starting materials 
that the students have developed themselves. 
This experiment was carried out in the University of Rhode Island’s second 
semester organic chemistry laboratory. The overarching goal of this experiment was to 
have the students perform a synthesis that utilized a majority of the skills and 
techniques covered throughout the semester. Students were graded based upon a 
predetermined rubric with substantial emphasis placed on the overall yield and purity 
of the desired product (See notes to the instructor for the complete rubric). 
Unfortunately, time typically does not allow for individual inspection of the flasks 
containing the student’s product, and as a result, reported yields are graded based on 
the honor system. Purity is judged solely on the student’s proton NMR where 
substantial points are deducted for non-solvent impurities.  
This experiment has been conducted, and subsequently improved upon, over the 
course of six semesters. The average class size per semester is approximately 90 
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students. In the most recent semester yields ranging from 5% - 75% were reported for 
students who were successfully able to complete the experiment. It should be noted 
that each semester is typically met with several individuals who are unable to obtain 
product, however, in most cases it was determined that this was the result of an error 
made during the purification process (See notes to the instructor). In instances where 
product is not obtained the student is given a standard NMR of their target molecule 
and is awarded no credit for product yield and purity. Representative student spectra 
for each peptide can be found in the supporting information. 
EXPERIMENTAL 
 
The experiment began with the synthesis of N-acetyl-L-phenylalanine. 
Students were instructed to measure 0.20 g of (L)-phenylalanine and synthesize the N-
protected amino acid according to a literature procedure.1 After suspending L-
phenylalanine in 1.0 M NaOH acetic anhydride is slowly, and carefully, added to the 
reaction vessel and allowed to stir uninterrupted for approximately 30 minutes. The 
product was extracted in ethyl acetate after acidifying the crude reaction mixture and 
was rotavapped to dryness. The reaction was very robust, producing yields >85%, 
with no evidence of unreacted starting material being observed after extraction. After 
the students had successfully isolated their product, the course instructor divided the 
class into three groups and each group was given a stock bottle containing a second 
amino acid that was protected at the carboxyl terminus as a methyl ester. These three 
amino acids were (L)-leucine methyl ester, (L)-valine methyl ester, and (L)-
phenylalanine methyl ester. Different amino acids were chosen in order to add 
variability to the purification and analysis processes in addition to the overall cost 
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effectiveness of each reagent. This protocol should be amenable to any other naturally 
occurring amino acid, however, only the aforementioned reagents were tested. By 
completing the table below students determined the necessary amounts of each of the 
reagents needed in order to construct their dipeptide Table 1.  All of the reagents 
shown in Table 1 were dissolved in 30 mL of DMF and were placed in the students’ 
assigned lab drawers where they remained until their next scheduled lab period, 
approximately 48 hours later. (Note: Reactions were not stirred during this time.)  
 
Table 1. Data Table For Dipeptide Synthesis 
 Ac-Phe R-OMea EDCa HOBt DIPEA 
MW (g/mol) 207.22  191.70 135.12 129.25 
d. (g/mL) - - - - 0.742 
Amount (g)      
Mol      
Equiv. 1 1 1.1 1.1 3 
a Weights correspond to the hydrochloride salt derivative 
 
The second day of the experiment commenced by extracting the dipeptide solution 
into EtOAc, drying with magnesium sulfate, and removing the solvent under reduced 
pressure. The crude reaction mixture was dissolved in CH2Cl2 and TLC analysis was 
performed, using hexanes and ethyl acetate, in order to purify the reaction mixture by 
flash chromatography. Due to the presence of phenylalanine in the dipeptide, students 
usually had no issue detecting their product under a standard 254 nm UV-lamp. A 
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solution of ninhydrin was also prepared so students assigned non-UV active amino 
acids (i.e. (L)-leucine methyl ester, (L)-valine methyl ester) could co-spot their TLC 
plate and detect unreacted starting material. 
After the correct solvent system was determined by trial and error, students 
prepared flash chromatography apparati resembling the image displayed in Figure 1. 
The benefits this flash chromatography system, in addition to instructions detailing 
how to assemble it, are reported in a prior communications.2 The crude reaction 
mixture was dissolved in a minimal amount of CH2Cl2 and loaded onto a disposable 
silica column using a 1 mL syringe. The fractions containing the desired dipeptide 
were placed into a preweighed flask and concentrated under reduced pressure. The 
resulting powders were left to dry until the next scheduled lab period, when yields and 
samples for NMR analysis were obtained. 
 
 
 
 
 
 
 
 
Figure 1. Flash Column Apparatus10 
Over the course of three years an excess of 400 students have completed this lab. 
This experiment has served as the final evaluation of the skills student’s have obtained 
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throughout a typical synthesis laboratory. When the dipeptide was appropriately 
isolated a typical yield within the 50% range was reported. The most common 
contaminants observed in the final NMRs were the student’s respective methyl ester 
and residual solvent peaks. Due to the fact this experiment was serving as a final 
exam, communication with the instructor was limited as students were encouraged to 
perform the experiment as independently as possible. As a result, we hypothesize 
greater yields and purities may be achieved with more instructor interaction.  
CONCLUSION 
 
In summation, the experiment described herein serves as an excellent final 
assessment of the skills obtained in a second-year organic synthesis laboratory. 
Peptide coupling is a topic of significant importance and should appeal to a wide array 
of students across multiple disciplines while providing a hands-on opportunity to 
explore one of the more fundamental concepts covered in both introductory and 
advanced life science courses.  
ASSOCIATED CONTENT 
 
Student handouts, notes to the instructor, and standard NMR spectra for each 
dipeptide can be found via the Internet at http://pubs.acs.org 
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Materials and Methods 
 All reagents were purchased from either Fisher Scientific or Sigma Aldrich and 
were used without further purification. NMR spectra were obtained using a Bruker 
300 MHz spectrometer in d6-DMSO.  
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Solution-Phase Synthesis of Dipeptides: A Capstone Project that Employs Key 
Techniques in an Organic Laboratory Course 
 
 
Throughout your organic chemistry tenure you have been taught the 
underlying principles necessary to construct simple organic molecules in the 
laboratory. In this lab you will see how the different branches of science can overlap 
as you strive to make one of life’s most important structures, a peptide. 
 
Thinking back to general biology you will 
recall that amino acids serve as the building blocks 
for life. Understanding how amino acid form 
peptides and proteins is pivotal for the development of vaccines and modern biologic 
drugs such as Enfuvirtide.  The general features of an amino acid is a central carbon 
atom that is covalently bound to an amino group, a carboxyl group, a hydrogen atom, 
and an R-group; and with the exception of 
glycine, R is defined as any alkyl chain that 
may contain heteroatoms (Figure 1). It is 
also important to note that stereochemistry 
plays an important role in peptide synthesis. 
You should take note that the central carbon atom present in naturally occurring amino 
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acids, with the exception of glycine, is chiral. You should remember from your first-
semester organic chemistry course that the terms Rectus, (R-), and Sinister, (S-), have 
been historically used to denote how a molecule rotates plane polarized light, where 
Rectus signifies clockwise rotation and Sinister signifies counter-clockwise rotation. 
In biological systems, the terms Dexter, (D-), and Laevus, (L-) are used, in replace of 
Rectus and Sinister, respectively, to represent a molecules chirality (Figure 2).  
Biological systems exist in a chiral environment, and all naturally occurring amino 
acids exist as the (L)-isomer. 
 
 How a molecule is oriented in space dramatically affects that molecules 
function. Speaking from a pharmaceutical standpoint, a drug’s spatial configuration 
can be the difference between a cough remedy and a potentially lethal drug. With that 
in mind, chemists always seek to create enantiopure compounds. One methodology 
used to synthesize enantiopure peptides is to use carbodiimine coupling reagents. The 
function of a carbodiimine is to activate the carboxyl terminus of an amino acid, 
converting it into a leaving group for a subsequent nucleophilic attack from the free 
amino terminus of a second amino acid. You have previously learned that carboxylic 
acids can be converted into amides via an acid chloride intermediate, which can be 
synthesized using either thionyl chloride (SOCl2) or oxalyl chloride [(COCl)2].  
Unfortunately, both of these reactions will partially racemize the chiral center of an 
amino acid.  Consequently carbodiimides coupling agents such as 
dicyclohexylcarbodiimide (DCC) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
were developed. 
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The scheme at the beginning of this handout shows the amino terminus of 
phenylalanine and the carboxyl terminus of a second amino acid are protected; 
meaning, they are substituted with groups that render them chemically inactive to 
peptide coupling conditions. Protecting groups are used to deactivate one side of an 
amino acid in order to provide selective coupling. These protecting groups are usually 
easily removed in acid/base workups in order to generate even longer peptide chains 
once the primary coupling has completed. It should be easy to envision the concept of 
the amino protecting group being removed from your dipeptide so that it may attack 
the free carboxylic terminus of another amino acid. This would in essence create a 
tripeptide. Alternatively, removal of both protecting groups will result in a naturally 
occurring peptide. 
Day 1 - Acyl Protection Of Phenylalanine: 
 
 
 
 
Reference: Young, E. P.; Campbell, A. J. Chem. Ed. 1982, 59, 701-702. 
 
Data Table: Have a completed copy of the following data table in your notebook 
prior to the beginning of lab. It is your responsibility to find the molecular weights and 
densities, if needed, before you arrive.  
 
1 M NaOH
O
OO
H2N
OH
O
N
H
OH
O
O
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 Phenylalanine Acetic Anhydride 1 M NaOH 
Molecular Weight   - 
Density - - - 
Amount    
mmol  - - 
Mole Ratio 1 - - 
 
Procedure:  
  Take a 50 mL round bottom flask and charge it with 0.200 g of phenylalanine, 
and 10.00 mL of 1.00 M NaOH. Stir the contents of your flask until phenylalanine is 
fully dissolved then add 1.00 mL of acetic anhydride. Allow your flask to stir 
uninterrupted for 30 minutes. During this time you will observe a sudden increase in 
the solution’s temperature. At the end of the 30 minutes, you will need to acidify your 
solution. Test your reaction with pH paper using a glass TLC capillary tube and 
acidify with 6.0 M HCl until you achieve a pH between 1 and 2. Be sure to do this 
very carefully and ensure proper mixing.  
Once you have achieved the desired pH, you will notice crystals beginning to 
precipitate out of the solution; if not, cap the flask and shake the contents vigorously 
to coax the crystals out of the solution. Pour the contents of you vial into a separatory 
funnel and add an additional 15 mL of water; use the additional water to properly rinse 
out your vial. Extract your product into EtOAc by washing the aqueous solution three 
times with 20 mL portions of EtOAc. The acylated amino acid product should be 
soluble in organic solvents, so it should be found in the EtOAc layer. Combine all 
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three organic layers into an Erlenmeyer flask and, using magnesium sulfate, dry the 
EtOAc solution. Collect the mother liquor by vacuum filtration to remove the 
magnesium sulfate, and pour it into a dry, preweighed round bottom flask. Remove the 
solvent via rotary evaporation and weigh the residue in the flask to obtain a yield. 
Place a small amount of the solid into a vial to be used in the future for TLC analysis.  
 
Synthesis Of The Dipeptide: 
 
 
 Your instructor will give you a second amino acid that is already protected on 
the carboxyl terminus; this is the “R-OMe” section of your data table. Ask your 
instructor for the molecular weight of this amino acid. When you are determining your 
molar equivalents, you are going to use your newly synthesized N-acyl-L-
phenylalanine as your limiting reagent. EDC is the peptide coupling agent and HOBt 
(1-hydroxybenzotriazole) is another activator with the purpose of further enhancing 
enantiopurity. 
 
 
 
 
H2N
O
O
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O
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 Ac-Phe R-OMe EDC HOBt Diisopropylethylamine 
MW      
Density - - - -  
Amount      
Mol      
Mole 
Ratio 
1 1 1.1 1.1 3 
 
 Add 30 mL of DMF to the flask containing your N-acyl-L-phenylalanine. Add 
EDC, HOBt, diisoproplyethylamine, and your assigned amino acid to your reaction 
vessel and shake the contents of the flask vigorously until all reagents are fully 
dissolved. It is important that you use a glass septum for this step; rubber septa have a 
tendency to contaminate reactions with phthalates. Once fully dissolved, place your 
stoppered, round bottom flask in your drawers and allow them to sit until your next lab 
period. 
Day 2 – Dipeptide Purification 
 EDC and HOBt are beneficial peptide coupling agents because they create 
water-soluble byproducts. You will be able to isolate the dipeptide and any unreacted 
amino acid starting material from DMF by performing an extraction. Using 75 mL of 
water, quench the reaction mixture and wash with 20 mL of EtOAc. Place the organic 
layer in a flask and wash the aqueous layer two more times using an additional 20 mL 
of EtOAc each time. Combine all three portions of EtOAc into your round bottom 
flask and remove the solvent under reduced pressure.  
 158 
 After rotary evaporation you will observe either a white power or a yellow oil 
in the flask. If oil is present it simply means that residual DMF remained in your 
organic layer. To remedy this, pour 10 mL of 1.0 M HCl into your flask; at which time 
a white precipitate should form. This precipitate contains your product and it should 
be soluble in organic solvents. Perform one final extraction using 20 mL of EtOAc, 
remove the solvent under reduced pressure, and discard the aqueous layer. 
 Your crude reaction mixture should now be a dry white powder. In order to 
perform TLC analysis, dissolve your product in 10 mL of CH2Cl2 and find an 
appropriate solvent system for flash purification by testing a variety of mixture of 
hexanes and EtOAc. You should observe 2 or 3 spots, and it will be up to you to 
determine which spot corresponds to your peptide. Start with a 1:1 of Hex:EtOAc (10 
mL total) and observe where your spots travel. Remember to co-spot your TLC plate 
with your acylated amino acid, methylated amino acid, and your extracted product. 
Adjust your solvent system accordingly by increasing or decreasing your EtOAc 
concentration while remembering to keep the overall volume of the solvent system at 
10 mL (i.e. if you decrease EtOAc by 1.0 mL be sure to add an additional 1.0 mL of 
hexanes). Once the appropriate solvent system has been determined (rf of desired 
product should be 0.3), show your instructor your TLC plate so he/she may confirm.  
Transfer your solution into a pre-weighed round bottom and rotavap off the 
excess CH2Cl2. Once your round bottom containing the crude product has been dried, 
dissolve the product in a minimal amount of CH2Cl2 (remember to use as little solvent 
as possible for this step). Load your sample into your flash column (remembering to 
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saturate the column in the solvent system that you just determine by TLC prior to 
sample loading) and isolate your desired spot.  
 Combine all of the test tubes that contain your isolated dipeptide into a dry, 
preweighed round bottom flask and rotavap off the solvent. Allow your sample to dry 
overnight and prepare a sample for NMR analysis using deuterated DMSO during the 
next class. 
  
HAZARDS 
Acetic anhydride (CAS# 108-24-71) is flammable and can cause irritation of 
the lungs, skin and eyes.  1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, 
CAS# 1892-57-5) is hazardous in case of eye contact (irritant), of ingestion, of 
inhalation. 1-Hydroxybenzotriazole hydrate (HOBT, CAS#: 123333-53-9) is explosive 
when dry, risk of explosion if heated under confinement.  Hydrochloric acid and 
sodium hydroxide solutions may cause skin irritation and eye damage upon contact.  
Solvent such a dimethylformamide (DMF, CAS# 68-12-2) is hazardous in case of skin 
or eye contact and by inhalation or ingestion.  Common solvents for normal-phase 
flash chromatography, such as ethyl acetate [CAS# 141-78-6] and hexanes [CAS# 
92112-69-1], are flammable.  Appropriate personal protective equipment should be 
used at all times, and the reagents should only be handled in a well-ventilated fume 
hood.  MSDS sheets are freely available from the vendor at 
http://www.sigmaaldrich.com. 
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Instructor Notes 
Inst. 1  
The addition of acetic anhydride to the solutions of (L)-phenylalanine in 1 
M NaOH is noticeably exothermic. Ensure that students are not holding 
their flask during addition. 
Inst. 2 
When acidifying the reaction solution to a pH of 1-2, crystals will begin to 
crash out of solution. The crystals are pure N-acetyl-L-phenylalanine; 
however, much of the product still remains in solution. It is easiest to 
perform an extraction using EtOAc without isolating the crystals by 
filtration. The crystals will readily dissolve in the organic layer. The 
crystals can be coaxed out of solution with vigorous shaking if it does 
crystallization does not spontaneousl occur. This is a good indicator or 
whether or not the appropriate pH has been reached. 
Inst. 3 
If no crystals are observed, we have found that this typically is the result of 
over-acidification. This problem is easily remedied using the 1 M NaOH 
solution used to carryout the acylation procedure. Over-acidification 
resulted in severely reduced recovery of the acylated product after 
extraction, as it remained in the aqueous layer. 
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Inst. 4 
If pH manipulation was performed correctly there was typically no 
evidence of unreacted (L)-phenylalanine present within the organic layer 
(TLC = 4% MeOH in CH2Cl2). 
Inst. 5 
N-Acetyl-L-phenylalanine will present as a yellow oil if not completely 
dried. 10 minutes under high vacuum typically allowed for white powder 
development. Continuing the experiment using the oil did not inhibit the 
reaction. 
Inst. 6 
When distributing the second amino acid be mindful as to whether or not it 
is the hydrochloride salt derivative. Let the students know the correct 
molecular weight to put into their data tables. 
Inst. 7 
EDC was chosen due to the extreme sensitivity some individuals 
experienced with DCC (i.e. skin irritation and severe rash). Also, DCC was 
found to still be present in the reaction after extraction, whereas no 
evidence of EDC was observed. 
Inst. 8 
Ninhydrin spray was necessary to elucidate (L)-valine methyl ester and 
(L)-leucine methyl ester. 
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Inst. 9 
The dipeptides were liquid loaded onto the columns using CH2Cl2 because 
they often did not fully dissolve in the Hex:EtOAc mixture necessary to 
perform column chromatography. Liquid loading volume depends on 
column size but in general do not exceed 2 mL of CH2Cl2 when using a 10 
g column. See reference 10 of the manuscript for details on the flash 
column apparatus system. 
 
Inst. 10 
Purification by adsorbing the crude reaction material onto silica provides 
the best separation. This method is slightly more costly, but may serve as a 
viable option for smaller classes. Biotage SNAP 10 g columns (Biotage 
HP-Sphere 25 um) provide a means for loading dry silica on top of a 
disposable silica cartage that can then be attached to the flash 
chromatography apparatus described.   
 
Inst. 11 
Purification difficulties arose from overloading the flash columns. Using a 
standard 10 g column no more than 2 mL of CH2Cl2 should be used to load 
the crude reaction material onto the column. If not all of the material can be 
dissolved in 2 mL then run the column twice. 
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Inst. 12 
It was found that students who did not obtain any product often did not 
perform the flash chromatography procedure correctly. Rather than 
spotting test tubes in order to determine if their product had successfully 
eluted from the column, several students simply stopped after 10 full test 
tubes had been collected (which was the outcome of a previous lab) and 
threw away their flash column. 
Inst. 13 
Rotomers present in final NMR of valine containing product. 
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N-Ac-(L)-Phe-(L)-Phe-OMe 
 
 
 
1H NMR (300 MHz, CDCl3): δ 8.43 (d, J = 8.0 Hz, 1H), 8.03 (d, J = 8.0 Hz, 1H), 
7.11 – 7.32 (m, 5 H), 4.47 – 4.49 (m, 2H), 3.59 (s, 3H), 2.90 – 3.09 (m, 3H), 2.69 (q, J 
= 10 Hz, 1H), 1.73 (s, 3H). 
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O
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Spectrum 1: Student 1H NMR of N-Ac-(L)-Phe-(L)-Phe-OMe 
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N-Ac-(L)-Phe-(L)-Val-OMe 
 
 
 
 
1H NMR (300 MHz, CDCl3): δ 8.4 (d, J = 8.2 Hz, 1H), 8.28 (d, J= 8.2 Hz, 1H), 8.12 
(d, J = 8.2 Hz, 1H), 7.15 – 7.28 (m, 5H), 4.61 – 4.77 (m, 1H), 4.14 – 4.21 (m, 1H), 
3.64 (s, 3H) 3.63 (s, 3H), 2.95 (td, J = 14.9, 14.4, 4.8 Hz, 1H), 2.68 – 2.79 (m, 1H), 
1.88 – 2.08 (m, 1H), 1.76 (s, 3H), 1.75 (s, 3H), 0.89 (t, J = 7.1 Hz, 4H), 0.79 (dd, J = 
6.8, 3.2 Hz, 2H). 
 
 
Rotomer Signals: 
 
δ = 8.4 + 8.28 (1H), 3.64 + 3.63 (3H)  
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Spectrum 2: Student 1H NMR of N-Ac-(L)-Phe-(L)-Val-OMe  
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N-Ac-(L)-Phe-(L)-Phe-OMe 
 
 
 
1H NMR (300 MHz, CDCl3):  δ 8.40 (d, J = 7.6 Hz, 1H), 8.08 (d, J = 8.5 Hz, 1H), 
7.26 (d, J = 4.3 Hz, 4H), 7.17 – 7.27 (m, 5H), 4.54 (m, 1H), 4.29 (m, 1H), 3.61 (s, 
3H), 2.98 (dd, J = 13.8, 4.2 Hz, 1H), 2.72 – 2.64 (m, 1H), 1.73 (s, 3H), 1.67 – 1.46 (m, 
3H), 0.90 (d, J = 6.2 Hz, 3H), 0.85 (d, J = 6.2 Hz, 3H). 
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Spectrum 3: Student 1H NMR of N-Ac-(L)-Phe-(L)-Leu-OMe  
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Hazards 
 
Acetic anhydride (CAS# 108-24-71) is flammable and can cause irritation of the 
lungs, skin and eyes.  1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, CAS# 
1892-57-5) is hazardous in case of eye contact (irritant), of ingestion, of inhalation. 
Some students may exhibit extreme skin sensitivity to carbodiimides and, as such, 
should be handeled with extreme care. 1-Hydroxybenzotriazole hydrate (HOBT, 
CAS#: 123333-53-9) is explosive when dry, risk of explosion if heated under 
confinement.  Hydrochloric acid and sodium hydroxide solutions may cause skin 
irritation and eye damage upon contact.  Solvent such a dimethylformamide (DMF, 
CAS# 68-12-2) is hazardous in case of skin or eye contact and by inhalation or 
ingestion.  Common solvents for normal-phase flash chromatography, such as ethyl 
acetate [CAS# 141-78-6] and hexanes [CAS# 92112-69-1], are flammable and 
hexanes is a known neurotoxin. Dichloromethane [CAS# 75-09-2] is a skin and eye 
irritant in addition to being a known carcinogen. Dimethyl sulfoxide – d6 [CAS# 2206-
27-1] is a flammable liquid. Appropriate personal protective equipment should be used 
at all times, and the reagents should only be handled in a well-ventilated fume hood.   
 
MSDS sheets are freely available from the vendor at http://www.sigmaaldrich.com. 
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Appendix I: Common Abbreviation and Symbols 
AcOH   acetic acid 
AgOAc  silver acetate 
bs   broad singlet 
BoNTA  botulinum nerurotoxic inhibitor A 
BoNT   botulinum nerurotoxic inhibitor 
n-BuLi   n-butyllithium 
Bz   benzyl 
CDCl3   deuterated chloroform 
((CD3)2CO)  deuterated acetone 
CO2Me  carboxylate group 
Cu(OAc)2  copper acetate 
Cu(OTf)2  copper triflate 
13C-NMR  carbon nuclear magnetic resonance 
DMSO-d6  deuterated dimethylsulfoxide 
DMF   dimethylformamide 
DMSO   dimethylsulfoxide 
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d    doublet 
dd   doublet of doublets 
EtOAc   ethylacetate 
FG   functional group 
GC/MS  gas chromatography/ mass spectrometry 
1H-NMR  proton nuclear magnetic resonance 
HRMS ESI  high resolution mass spectrum electrospray ionization 
LRMS EI  low resolution mass spectrum electron impact 
MOM   methoxymethyl 
Me   methyl 
MW   microwave 
MHz   megahertz 
MeO   methoxy 
m   multiplet 
NaOH   sodiumhydroxide 
NPhth   phthalimide  
Pd(OAc)2  palladium acetate 
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PivOH   pivalic acid 
PhH   benzene 
PhI   iodobenzene 
Rf   retention factor 
s    singlet 
SEM   (trimethylsilyl)ethoxy methyl   
SEMCl  (trimethylsilyl)ethoxy methyl  chloride 
t    triplet 
TBAF   tetra-n-butylammoniumfluoride 
TLC   thin layer chromatography 
TMS   trimethylsilane 
Tos   tosyl 
 
 
 
